Novel ligands for metal complexes containing five-membered ring fused on pyridine or pyrimidine ring combined with partially fluorinated side chains exhibiting improved external quantum efficiency and lifetime are disclosed.

Patent
   RE48809
Priority
May 15 2015
Filed
Sep 26 2019
Issued
Nov 02 2021
Expiry
Mar 21 2036
Assg.orig
Entity
Large
0
144
window open
1. A compound comprising a ligand lA of formula I:
##STR00131##
wherein ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring;
wherein R is fused to ring B and has a structure of formula ii:
##STR00132##
wherein the wave lines indicate bonds to ring B;
wherein R1 represents mono, di, tri, or tetra substitution, or no substitution;
wherein R2 represents mono or di substitution, or no substitution;
wherein X1, X2, X3, and X4 are each independently carbon or nitrogen;
wherein at least one of X1 to X4 is nitrogen;
wherein at least two adjacent of X1, X2, X3, and X4 are carbon and fuse to R;
wherein X is selected from the group consisting of BR′, NR′, PR′, O, S, Se, C═O, S═O, SO2, CR′R″, SiR′R″, and GeR′R″;
wherein R1, R2, R3, R4, R′, and R″ are each independently selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substituents are optionally joined to form into a ring;
wherein at least one of R3 and R4 comprises a chemical group selected from the group consisting of alkyl, cycloalkyl, partially fluorinated alkyl, partially fluorinated cycloalkyl, and combinations thereof;
wherein the ligand lA is coordinated to a metal m;
wherein the ligand lA is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand; and
wherein m is optionally coordinated to other ligands.
20. A formulation comprising a compound comprising a ligand lA of formula I:
##STR00163##
wherein ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring;
wherein R is fused to ring B and has a structure of formula ii:
##STR00164##
wherein the wave lines indicate bonds to ring B;
wherein R1 represents mono, di, tri, or tetra substitution, or no substitution;
wherein R2 represents mono or di substitution, or no substitution;
wherein X1, X2, X3, and X4 are each independently carbon or nitrogen;
wherein at least one of X1 to X4 is nitrogen;
wherein at least two adjacent of X1, X2, X3, and X4 are carbon and fuse to R;
wherein X is selected from the group consisting of BR′, NR′, PR′, O, S, Se, C═O, S═O, SO2, CR′R″, SiR′R″, and GeR′R″;
wherein R1, R2, R3, R4, R′, and R″ are each independently selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substituents are optionally joined to form into a ring;
wherein at least one of R3 and R4 comprises a chemical group selected from the group consisting of alkyl, cycloalkyl, partially fluorinated alkyl, partially fluorinated cycloalkyl, and combinations thereof;
wherein the ligand lA is coordinated to a metal m;
wherein the ligand lA is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand; and
wherein m is optionally coordinated to other ligands.
15. A first device comprising a first organic light emitting device, the first organic light emitting device comprising:
an anode;
a cathode; and
an organic layer, disposed between the anode and the cathode, comprising a compound comprising a ligand lA of formula I:
##STR00156##
wherein ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring;
wherein R is fused to ring B and has a structure of formula ii:
##STR00157##
wherein the wave lines indicate bonds to ring B;
wherein R1 represents mono, di, tri, or tetra substitution, or no substitution;
wherein R2 represents mono or di substitution, or no substitution;
wherein X1, X2, X3, and X4 are each independently carbon or nitrogen;
wherein at least one of X1 to X4 is nitrogen;
wherein at least two adjacent of X1, X2, X3, and X4 are carbon and fuse to R;
wherein X is selected from the group consisting of BR′, NR′, PR′, O, S, Se, C═O, S═O, SO2, CR′R″, SiR′R″, and GeR′R″;
wherein R1, R2, R3, R4, R′, and R″ are each independently selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substituents are optionally joined to form into a ring;
wherein at least one of R3 and R4 comprises a chemical group selected from the group consisting of alkyl, cycloalkyl, partially fluorinated alkyl, partially fluorinated cycloalkyl, and combinations thereof;
wherein lA is coordinated to a metal m;
wherein lA is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand; and
wherein m is optionally coordinated to other ligands.
2. The compound of claim 1, wherein m is selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Au, and Cu.
3. The compound of claim 1, wherein the ligand lA is selected from the group consisting of:
##STR00133## ##STR00134##
4. The compound of claim 1, wherein the ligand lA is:
##STR00135##
0. 5. The compound of claim 1, wherein at least one of R3 and R4 is a chemical group selected from the group consisting of partially fluorinated alkyl, partially fluorinated cycloalkyl, and combinations thereof.
6. The compound of claim 1, wherein R3 and R4 are not hydrogen.
0. 7. The compound of claim 1, wherein at least one of X1, X2, X3, and X4 is nitrogen.
8. The compound of claim 1, wherein at least one of R3 and R4 is selected from the group consisting of:
##STR00136## ##STR00137## ##STR00138## ##STR00139## ##STR00140## ##STR00141##
9. The compound of claim 1, wherein R3 and R4 are joined to form a ring structure selected from the group consisting of:
##STR00142## ##STR00143##
10. The compound of claim 1, wherein the ligand lA is selected from the group consisting of:
##STR00144##
11. The compound of claim 8, wherein the ligand lA is selected from the group consisting of lA1 through lA750 defined as follows:
lA1 through lA375 are based on a structure of formula IV,
##STR00145##
in which R3, R4, and X are defined as:
ligand R3 R4 X
lA1 H RA2 O
lA2 RA2 RA2 O
lA3 RA3 RA2 O
lA4 RA14 RA2 O
lA5 RA22 RA2 O
lA6 RA28 RA2 O
lA7 H RA3 O
lA8 RA2 RA3 O
lA9 RA3 RA3 O
lA10 RA14 RA3 O
lA11 RA22 RA3 O
lA12 RA28 RA3 O
lA13 H RA14 O
lA14 RA2 RA14 O
lA15 RA3 RA14 O
lA16 RA14 RA14 O
lA17 RA22 RA14 O
lA18 RA28 RA14 O
lA19 H RA22 O
lA20 RA2 RA22 O
lA21 RA3 RA22 O
lA22 RA14 RA22 O
lA23 RA22 RA22 O
lA24 RA28 RA22 O
lA25 H RA28 O
lA26 RA2 RA28 O
lA27 RA3 RA28 O
lA28 RA14 RA28 O
lA29 RA22 RA28 O
lA30 RA28 RA28 O
lA31 RA2 H O
lA32 RA3 H O
lA33 RA14 H O
lA34 RA22 H O
lA35 RA28 H O
lA36 RA2 RB1 O
lA37 RA3 RB1 O
lA38 RA14 RB1 O
lA39 RA22 RB1 O
lA40 RA28 RB1 O
lA41 RA2 RB2 O
lA42 RA3 RB2 O
lA43 RA14 RB2 O
lA44 RA22 RB2 O
lA45 RA28 RB2 O
lA46 RA2 RB3 O
lA47 RA3 RB3 O
lA48 RA14 RB3 O
lA49 RA22 RB3 O
lA50 RA28 RB3 O
lA51 RA2 RB4 O
lA52 RA3 RB4 O
lA53 RA14 RB4 O
lA54 RA22 RB4 O
lA55 RA28 RB4 O
lA56 RB1 RA2 O
lA57 RB1 RA3 O
lA58 RB1 RA14 O
lA59 RB1 RA22 O
lA60 RB1 RA28 O
lA61 RB2 RA2 O
lA62 RB2 RA3 O
lA63 RB2 RA14 O
lA64 RB2 RA22 O
lA65 RB2 RA28 O
lA66 RB3 RA2 O
lA67 RB3 RA3 O
lA68 RB3 RA14 O
lA69 RB3 RA22 O
lA70 RB3 RA28 O
lA71 RB4 RA2 O
lA72 RB4 RA3 O
lA73 RB4 RA14 O
lA74 RB4 RA22 O
lA75 RB4 RA28 O
lA76 H RA2 S
lA77 RA2 RA2 S
lA78 RA3 RA2 S
lA79 RA14 RA2 S
lA80 RA22 RA2 S
lA81 RA28 RA2 S
lA82 H RA3 S
lA83 RA2 RA3 S
lA84 RA3 RA3 S
lA85 RA14 RA3 S
lA86 RA22 RA3 S
lA87 RA28 RA3 S
lA88 H RA14 S
lA89 RA2 RA14 S
lA90 RA3 RA14 S
lA91 RA14 RA14 S
lA92 RA22 RA14 S
lA93 RA28 RA14 S
lA94 H RA22 S
lA95 RA2 RA22 S
lA96 RA3 RA22 S
lA97 RA14 RA22 S
lA98 RA22 RA22 S
lA99 RA28 RA22 S
lA100 H RA28 S
lA101 RA2 RA28 S
lA102 RA3 RA28 S
lA103 RA14 RA28 S
lA104 RA22 RA28 S
lA105 RA28 RA28 S
lA106 RA2 H S
lA107 RA3 H S
lA108 RA14 H S
lA109 RA22 H S
lA110 RA28 H S
lA111 RA2 RB1 S
lA112 RA3 RB1 S
lA113 RA14 RB1 S
lA114 RA22 RB1 S
lA115 RA28 RB1 S
lA116 RA2 RB2 S
lA117 RA3 RB2 S
lA118 RA14 RB2 S
lA119 RA22 RB2 S
lA120 RA28 RB2 S
lA121 RA2 RB3 S
lA122 RA3 RB3 S
lA123 RA14 RB3 S
lA124 RA22 RB3 S
lA125 RA28 RB3 S
lA126 RA2 RB4 S
lA127 RA3 RB4 S
lA128 RA14 RB4 S
lA129 RA22 RB4 S
lA130 RA28 RB4 S
lA131 RB1 RA2 S
lA132 RB1 RA3 S
lA133 RB1 RA14 S
lA134 RB1 RA22 S
lA135 RB1 RA28 S
lA136 RB2 RA2 S
lA137 RB2 RA3 S
lA138 RB2 RA14 S
lA139 RB2 RA22 S
lA140 RB2 RA28 S
lA141 RB3 RA2 S
lA142 RB3 RA3 S
lA143 RB3 RA14 S
lA144 RB3 RA22 S
lA145 RB3 RA28 S
lA146 RB4 RA2 S
lA147 RB4 RA3 S
lA148 RB4 RA14 S
lA149 RB4 RA22 S
lA150 RB4 RA28 S
lA151 H RA2 C(CH3)2
lA152 RA2 RA2 C(CH3)2
lA153 RA3 RA2 C(CH3)2
lA154 RA14 RA2 C(CH3)2
lA155 RA22 RA2 C(CH3)2
lA156 RA28 RA2 C(CH3)2
lA157 H RA3 C(CH3)2
lA158 RA2 RA3 C(CH3)2
lA159 RA3 RA3 C(CH3)2
lA160 RA14 RA3 C(CH3)2
lA161 RA22 RA3 C(CH3)2
lA162 RA28 RA3 C(CH3)2
lA163 H RA14 C(CH3)2
lA164 RA2 RA14 C(CH3)2
lA165 RA3 RA14 C(CH3)2
lA166 RA14 RA14 C(CH3)2
lA167 RA22 RA14 C(CH3)2
lA168 RA28 RA14 C(CH3)2
lA169 H RA22 C(CH3)2
lA170 RA2 RA22 C(CH3)2
lA171 RA3 RA22 C(CH3)2
lA172 RA14 RA22 C(CH3)2
lA173 RA22 RA22 C(CH3)2
lA174 RA28 RA22 C(CH3)2
lA175 H RA28 C(CH3)2
lA176 RA2 RA28 C(CH3)2
lA177 RA3 RA28 C(CH3)2
lA178 RA14 RA28 C(CH3)2
lA179 RA22 RA28 C(CH3)2
lA180 RA28 RA28 C(CH3)2
lA181 RA2 H C(CH3)2
lA182 RA3 H C(CH3)2
lA183 RA14 H C(CH3)2
lA184 RA22 H C(CH3)2
lA185 RA28 H C(CH3)2
lA186 RA2 RB1 C(CH3)2
lA187 RA3 RB1 C(CH3)2
lA188 RA14 RB1 C(CH3)2
lA189 RA22 RB1 C(CH3)2
lA190 RA28 RB1 C(CH3)2
lA191 RA2 RB2 C(CH3)2
lA192 RA3 RB2 C(CH3)2
lA193 RA14 RB2 C(CH3)2
lA194 RA22 RB2 C(CH3)2
lA195 RA28 RB2 C(CH3)2
lA196 RA2 RB3 C(CH3)2
lA197 RA3 RB3 C(CH3)2
lA198 RA14 RB3 C(CH3)2
lA199 RA22 RB3 C(CH3)2
lA200 RA28 RB3 C(CH3)2
lA201 RA2 RB4 C(CH3)2
lA202 RA3 RB4 C(CH3)2
lA203 RA14 RB4 C(CH3)2
lA204 RA22 RB4 C(CH3)2
lA205 RA28 RB4 C(CH3)2
lA206 RB1 RA2 C(CH3)2
lA207 RB1 RA3 C(CH3)2
lA208 RB1 RA14 C(CH3)2
lA209 RB1 RA22 C(CH3)2
lA210 RB1 RA28 C(CH3)2
lA211 RB2 RA2 C(CH3)2
lA212 RB2 RA3 C(CH3)2
lA213 RB2 RA14 C(CH3)2
lA214 RB2 RA22 C(CH3)2
lA215 RB2 RA28 C(CH3)2
lA216 RB3 RA2 C(CH3)2
lA217 RB3 RA3 C(CH3)2
lA218 RB3 RA14 C(CH3)2
lA219 RB3 RA22 C(CH3)2
lA220 RB3 RA28 C(CH3)2
lA221 RB4 RA2 C(CH3)2
lA222 RB4 RA3 C(CH3)2
lA223 RB4 RA14 C(CH3)2
lA224 RB4 RA22 C(CH3)2
lA225 RB4 RA28 C(CH3)2
lA226 H RA2 NCH3
lA227 RA2 RA2 NCH3
lA228 RA3 RA2 NCH3
lA229 RA14 RA2 NCH3
lA230 RA22 RA2 NCH3
lA231 RA28 RA2 NCH3
lA232 H RA3 NCH3
lA233 RA2 RA3 NCH3
lA234 RA3 RA3 NCH3
lA235 RA14 RA3 NCH3
lA236 RA22 RA3 NCH3
lA237 RA28 RA3 NCH3
lA238 H RA14 NCH3
lA239 RA2 RA14 NCH3
lA240 RA3 RA14 NCH3
lA241 RA14 RA14 NCH3
lA242 RA22 RA14 NCH3
lA243 RA28 RA14 NCH3
lA244 H RA22 NCH3
lA245 RA2 RA22 NCH3
lA246 RA3 RA22 NCH3
lA247 RA14 RA22 NCH3
lA248 RA22 RA22 NCH3
lA249 RA28 RA22 NCH3
lA250 H RA28 NCH3
lA251 RA2 RA28 NCH3
lA252 RA3 RA28 NCH3
lA253 RA14 RA28 NCH3
lA254 RA22 RA28 NCH3
lA255 RA28 RA28 NCH3
lA256 RA2 H NCH3
lA257 RA3 H NCH3
lA258 RA14 H NCH3
lA259 RA22 H NCH3
lA260 RA28 H NCH3
lA261 RA2 RB1 NCH3
lA262 RA3 RB1 NCH3
lA263 RA14 RB1 NCH3
lA264 RA22 RB1 NCH3
lA265 RA28 RB1 NCH3
lA266 RA2 RB2 NCH3
lA267 RA3 RB2 NCH3
lA268 RA14 RB2 NCH3
lA269 RA22 RB2 NCH3
lA270 RA28 RB2 NCH3
lA271 RA2 RB3 NCH3
lA272 RA3 RB3 NCH3
lA273 RA14 RB3 NCH3
lA274 RA22 RB3 NCH3
lA275 RA28 RB3 NCH3
lA276 RA2 RB4 NCH3
lA277 RA3 RB4 NCH3
lA278 RA14 RB4 NCH3
lA279 RA22 RB4 NCH3
lA280 RA28 RB4 NCH3
lA281 RA2 RB1 NCH3
lA282 RA3 RB1 NCH3
lA283 RA14 RB1 NCH3
lA284 RA22 RB1 NCH3
lA285 RA28 RB1 NCH3
lA286 RA2 RB2 NCH3
lA287 RA3 RB2 NCH3
lA288 RA14 RB2 NCH3
lA289 RA22 RB2 NCH3
lA290 RA28 RB2 NCH3
lA291 RA2 RB3 NCH3
lA292 RA3 RB3 NCH3
lA293 RA14 RB3 NCH3
lA294 RA22 RB3 NCH3
lA295 RA28 RB3 NCH3
lA296 RA2 RB4 NCH3
lA297 RA3 RB4 NCH3
lA298 RA14 RB4 NCH3
lA299 RA22 RB4 NCH3
lA300 RA28 RB4 NCH3
lA301 H RA2 N(isobutyl)
lA302 RA2 RA2 N(isobutyl)
lA303 RA3 RA2 N(isobutyl)
lA304 RA14 RA2 N(isobutyl)
lA305 RA22 RA2 N(isobutyl)
lA306 RA28 RA2 N(isobutyl)
lA307 H RA3 N(isobutyl)
lA308 RA2 RA3 N(isobutyl)
lA309 RA3 RA3 N(isobutyl)
lA310 RA14 RA3 N(isobutyl)
lA311 RA22 RA3 N(isobutyl)
lA312 RA28 RA3 N(isobutyl)
lA313 H RA14 N(isobutyl)
lA314 RA2 RA14 N(isobutyl)
lA315 RA3 RA14 N(isobutyl)
lA316 RA14 RA14 N(isobutyl)
lA317 RA22 RA14 N(isobutyl)
lA318 RA28 RA14 N(isobutyl)
lA319 H RA22 N(isobutyl)
lA320 RA2 RA22 N(isobutyl)
lA321 RA3 RA22 N(isobutyl)
lA322 RA14 RA22 N(isobutyl)
lA323 RA22 RA22 N(isobutyl)
lA324 RA28 RA22 N(isobutyl)
lA325 H RA28 N(isobutyl)
lA326 RA2 RA28 N(isobutyl)
lA327 RA3 RA28 N(isobutyl)
lA328 RA14 RA28 N(isobutyl)
lA329 RA22 RA28 N(isobutyl)
lA330 RA28 RA28 N(isobutyl)
lA331 RA2 H N(isobutyl)
lA332 RA3 H N(isobutyl)
lA333 RA14 H N(isobutyl)
lA334 RA22 H N(isobutyl)
lA335 RA28 H N(isobutyl)
lA336 RA2 RB1 N(isobutyl)
lA337 RA3 RB1 N(isobutyl)
lA338 RA14 RB1 N(isobutyl)
lA339 RA22 RB1 N(isobutyl)
lA340 RA28 RB1 N(isobutyl)
lA341 RA2 RB2 N(isobutyl)
lA342 RA3 RB2 N(isobutyl)
lA343 RA14 RB2 N(isobutyl)
lA344 RA22 RB2 N(isobutyl)
lA345 RA28 RB2 N(isobutyl)
lA346 RA2 RB3 N(isobutyl)
lA347 RA3 RB3 N(isobutyl)
lA348 RA14 RB3 N(isobutyl)
lA349 RA22 RB3 N(isobutyl)
lA350 RA28 RB3 N(isobutyl)
lA351 RA2 RB4 N(isobutyl)
lA352 RA3 RB4 N(isobutyl)
lA353 RA14 RB4 N(isobutyl)
lA354 RA22 RB4 N(isobutyl)
lA355 RA28 RB4 N(isobutyl)
lA356 RB1 RA2 N(isobutyl)
lA357 RB1 RA3 N(isobutyl)
lA358 RB1 RA14 N(isobutyl)
lA359 RB1 RA22 N(isobutyl)
lA360 RB1 RA28 N(isobutyl)
lA361 RB2 RA2 N(isobutyl)
lA362 RB2 RA3 N(isobutyl)
lA363 RB2 RA14 N(isobutyl)
lA364 RB2 RA22 N(isobutyl)
lA365 RB2 RA28 N(isobutyl)
lA366 RB3 RA2 N(isobutyl)
lA367 RB3 RA3 N(isobutyl)
lA368 RB3 RA14 N(isobutyl)
lA369 RB3 RA22 N(isobutyl)
lA370 RB3 RA28 N(isobutyl)
lA371 RB4 RA2 N(isobutyl)
lA372 RB4 RA3 N(isobutyl)
lA373 RB4 RA14 N(isobutyl)
lA374 RB4 RA22 N(isobutyl)
lA375 RB4 RA28 N(isobutyl)
and lA376 through lA750 are based on a structure of formula V,
##STR00146##
in which R3, R4, and X are defined as:
ligand R3 R4 X
lA376 H RA2 O
lA377 RA2 RA2 O
lA378 RA3 RA2 O
lA379 RA14 RA2 O
lA380 RA22 RA2 O
lA381 RA28 RA2 O
lA382 H RA3 O
lA383 RA2 RA3 O
lA384 RA3 RA3 O
lA385 RA14 RA3 O
lA386 RA22 RA3 O
lA387 RA28 RA3 O
lA388 H RA14 O
lA389 RA2 RA14 O
lA390 RA3 RA14 O
lA391 RA14 RA14 O
lA392 RA22 RA14 O
lA393 RA28 RA14 O
lA394 H RA22 O
lA395 RA2 RA22 O
lA396 RA3 RA22 O
lA397 RA14 RA22 O
lA398 RA22 RA22 O
lA399 RA28 RA22 O
lA400 H RA28 O
lA401 RA2 RA28 O
lA402 RA3 RA28 O
lA403 RA14 RA28 O
lA404 RA22 RA28 O
lA405 RA28 RA28 O
lA406 RA2 H O
lA407 RA3 H O
lA408 RA14 H O
lA409 RA22 H O
lA410 RA28 H O
lA411 RA2 RB1 O
lA412 RA3 RB1 O
lA413 RA14 RB1 O
lA414 RA22 RB1 O
lA415 RA28 RB1 O
lA416 RA2 RB2 O
lA417 RA3 RB2 O
lA418 RA14 RB2 O
lA419 RA22 RB2 O
lA420 RA28 RB2 O
lA421 RA2 RB3 O
lA422 RA3 RB3 O
lA423 RA14 RB3 O
lA424 RA22 RB3 O
lA425 RA28 RB3 O
lA426 RA2 RB4 O
lA427 RA3 RB4 O
lA428 RA14 RB4 O
lA429 RA22 RB4 O
lA430 RA28 RB4 O
lA431 RB1 RA2 O
lA432 RB1 RA3 O
lA433 RB1 RA14 O
lA434 RB1 RA22 O
lA435 RB1 RA28 O
lA436 RB2 RA2 O
lA437 RB2 RA3 O
lA438 RB2 RA14 O
lA439 RB2 RA22 O
lA440 RB2 RA28 O
lA441 RB3 RA2 O
lA442 RB3 RA3 O
lA443 RB3 RA14 O
lA444 RB3 RA22 O
lA445 RB3 RA28 O
lA446 RB4 RA2 O
lA447 RB4 RA3 O
lA448 RB4 RA14 O
lA449 RB4 RA22 O
lA450 RB4 RA28 O
lA451 H RA2 S
lA452 RA2 RA2 S
lA453 RA3 RA2 S
lA454 RA14 RA2 S
lA455 RA22 RA2 S
lA456 RA28 RA2 S
lA457 H RA3 S
lA458 RA2 RA3 S
lA459 RA3 RA3 S
lA460 RA14 RA3 S
lA461 RA22 RA3 S
lA462 RA28 RA3 S
lA463 H RA14 S
lA464 RA2 RA14 S
lA465 RA3 RA14 S
lA466 RA14 RA14 S
lA467 RA22 RA14 S
lA468 RA28 RA14 S
lA469 H RA22 S
lA470 RA2 RA22 S
lA471 RA3 RA22 S
lA472 RA14 RA22 S
lA473 RA22 RA22 S
lA474 RA28 RA22 S
lA475 H RA28 S
lA476 RA2 RA28 S
lA477 RA3 RA28 S
lA478 RA14 RA28 S
lA479 RA22 RA28 S
lA480 RA28 RA28 S
lA481 RA2 H S
lA482 RA3 H S
lA483 RA14 H S
lA484 RA22 H S
lA485 RA28 H S
lA486 RA2 RB1 S
lA487 RA3 RB1 S
lA488 RA14 RB1 S
lA489 RA22 RB1 S
lA490 RA28 RB1 S
lA491 RA2 RB2 S
lA492 RA3 RB2 S
lA493 RA14 RB2 S
lA494 RA22 RB2 S
lA495 RA28 RB2 S
lA496 RA2 RB3 S
lA497 RA3 RB3 S
lA498 RA14 RB3 S
lA499 RA22 RB3 S
lA500 RA28 RB3 S
lA501 RA2 RB4 S
lA502 RA3 RB4 S
lA503 RA14 RB4 S
lA504 RA22 RB4 S
lA505 RA28 RB4 S
lA506 RB1 RA2 S
lA507 RB1 RA3 S
lA508 RB1 RA14 S
lA509 RB1 RA22 S
lA510 RB1 RA28 S
lA511 RB2 RA2 S
lA512 RB2 RA3 S
lA513 RB2 RA14 S
lA514 RB2 RA22 S
lA515 RB2 RA28 S
lA516 RB3 RA2 S
lA517 RB3 RA3 S
lA518 RB3 RA14 S
lA519 RB3 RA22 S
lA520 RB3 RA28 S
lA521 RB4 RA2 S
lA522 RB4 RA3 S
lA523 RB4 RA14 S
lA524 RB4 RA22 S
lA525 RB4 RA28 S
lA526 H RA2 C(CH3)2
lA527 RA2 RA2 C(CH3)2
lA528 RA3 RA2 C(CH3)2
lA529 RA14 RA2 C(CH3)2
lA530 RA22 RA2 C(CH3)2
lA531 RA28 RA2 C(CH3)2
lA532 H RA3 C(CH3)2
lA533 RA2 RA3 C(CH3)2
lA534 RA3 RA3 C(CH3)2
lA535 RA14 RA3 C(CH3)2
lA536 RA22 RA3 C(CH3)2
lA537 RA28 RA3 C(CH3)2
lA538 H RA14 C(CH3)2
lA539 RA2 RA14 C(CH3)2
lA540 RA3 RA14 C(CH3)2
lA541 RA14 RA14 C(CH3)2
lA542 RA22 RA14 C(CH3)2
lA543 RA28 RA14 C(CH3)2
lA544 H RA22 C(CH3)2
lA545 RA2 RA22 C(CH3)2
lA546 RA3 RA22 C(CH3)2
lA547 RA14 RA22 C(CH3)2
lA548 RA22 RA22 C(CH3)2
lA549 RA28 RA22 C(CH3)2
lA550 H RA28 C(CH3)2
lA551 RA2 RA28 C(CH3)2
lA552 RA3 RA28 C(CH3)2
lA553 RA14 RA28 C(CH3)2
lA554 RA22 RA28 C(CH3)2
lA555 RA28 RA28 C(CH3)2
lA556 RA2 H C(CH3)2
lA557 RA3 H C(CH3)2
lA558 RA14 H C(CH3)2
lA559 RA22 H C(CH3)2
lA560 RA28 H C(CH3)2
lA561 RA2 RB1 C(CH3)2
lA562 RA3 RB1 C(CH3)2
lA563 RA14 RB1 C(CH3)2
lA564 RA22 RB1 C(CH3)2
lA565 RA28 RB1 C(CH3)2
lA566 RA2 RB2 C(CH3)2
lA567 RA3 RB2 C(CH3)2
lA568 RA14 RB2 C(CH3)2
lA569 RA22 RB2 C(CH3)2
lA570 RA28 RB2 C(CH3)2
lA571 RA2 RB3 C(CH3)2
lA572 RA3 RB3 C(CH3)2
lA573 RA14 RB3 C(CH3)2
lA574 RA22 RB3 C(CH3)2
lA575 RA28 RB3 C(CH3)2
lA576 RA2 RB4 C(CH3)2
lA577 RA3 RB4 C(CH3)2
lA578 RA14 RB4 C(CH3)2
lA579 RA22 RB4 C(CH3)2
lA580 RA28 RB4 C(CH3)2
lA581 RB1 RA2 C(CH3)2
lA582 RB1 RA3 C(CH3)2
lA583 RB1 RA14 C(CH3)2
lA584 RB1 RA22 C(CH3)2
lA585 RB1 RA28 C(CH3)2
lA586 RB2 RA2 C(CH3)2
lA587 RB2 RA3 C(CH3)2
lA588 RB2 RA14 C(CH3)2
lA589 RB2 RA22 C(CH3)2
lA590 RB2 RA28 C(CH3)2
lA591 RB3 RA2 C(CH3)2
lA592 RB3 RA3 C(CH3)2
lA593 RB3 RA14 C(CH3)2
lA594 RB3 RA22 C(CH3)2
lA595 RB3 RA28 C(CH3)2
lA596 RB4 RA2 C(CH3)2
lA597 RB4 RA3 C(CH3)2
lA598 RB4 RA14 C(CH3)2
lA599 RB4 RA22 C(CH3)2
lA600 RB4 RA28 C(CH3)2
lA601 H RA2 NCH3
lA602 RA2 RA2 NCH3
lA603 RA3 RA2 NCH3
lA604 RA14 RA2 NCH3
lA605 RA22 RA2 NCH3
lA606 RA28 RA2 NCH3
lA607 H RA3 NCH3
lA608 RA2 RA3 NCH3
lA609 RA3 RA3 NCH3
lA610 RA14 RA3 NCH3
lA611 RA22 RA3 NCH3
lA612 RA28 RA3 NCH3
lA613 H RA14 NCH3
lA614 RA2 RA14 NCH3
lA615 RA3 RA14 NCH3
lA616 RA14 RA14 NCH3
lA617 RA22 RA14 NCH3
lA618 RA28 RA14 NCH3
lA619 H RA22 NCH3
lA620 RA2 RA22 NCH3
lA621 RA3 RA22 NCH3
lA622 RA14 RA22 NCH3
lA623 RA22 RA22 NCH3
lA624 RA28 RA22 NCH3
lA625 H RA28 NCH3
lA626 RA2 RA28 NCH3
lA627 RA3 RA28 NCH3
lA628 RA14 RA28 NCH3
lA629 RA22 RA28 NCH3
lA630 RA28 RA28 NCH3
lA631 RA2 H NCH3
lA632 RA3 H NCH3
lA633 RA14 H NCH3
lA634 RA22 H NCH3
lA635 RA28 H NCH3
lA636 RA2 RB1 NCH3
lA637 RA3 RB1 NCH3
lA638 RA14 RB1 NCH3
lA639 RA22 RB1 NCH3
lA640 RA28 RB1 NCH3
lA641 RA2 RB2 NCH3
lA642 RA3 RB2 NCH3
lA643 RA14 RB2 NCH3
lA644 RA22 RB2 NCH3
lA645 RA28 RB2 NCH3
lA646 RA2 RB3 NCH3
lA647 RA3 RB3 NCH3
lA648 RA14 RB3 NCH3
lA649 RA22 RB3 NCH3
lA650 RA28 RB3 NCH3
lA651 RA2 RB4 NCH3
lA652 RA3 RB4 NCH3
lA653 RA14 RB4 NCH3
lA654 RA22 RB4 NCH3
lA655 RA28 RB4 NCH3
lA656 RA2 RB1 NCH3
lA657 RA3 RB1 NCH3
lA658 RA14 RB1 NCH3
lA659 RA22 RB1 NCH3
lA660 RA28 RB1 NCH3
lA661 RA2 RB2 NCH3
lA662 RA3 RB2 NCH3
lA663 RA14 RB2 NCH3
lA664 RA22 RB2 NCH3
lA665 RA28 RB2 NCH3
lA666 RA2 RB3 NCH3
lA667 RA3 RB3 NCH3
lA668 RA14 RB3 NCH3
lA669 RA22 RB3 NCH3
lA670 RA28 RB3 NCH3
lA671 RA2 RB4 NCH3
lA672 RA3 RB4 NCH3
lA673 RA14 RB4 NCH3
lA674 RA22 RB4 NCH3
lA675 RA28 RB4 NCH3
lA676 H RA2 N(isobutyl)
lA677 RA2 RA2 N(isobutyl)
lA678 RA3 RA2 N(isobutyl)
lA679 RA14 RA2 N(isobutyl)
lA680 RA22 RA2 N(isobutyl)
lA681 RA28 RA2 N(isobutyl)
lA682 H RA3 N(isobutyl)
lA683 RA2 RA3 N(isobutyl)
lA684 RA3 RA3 N(isobutyl)
lA685 RA14 RA3 N(isobutyl)
lA686 RA22 RA3 N(isobutyl)
lA687 RA28 RA3 N(isobutyl)
lA688 H RA14 N(isobutyl)
lA689 RA2 RA14 N(isobutyl)
lA690 RA3 RA14 N(isobutyl)
lA691 RA14 RA14 N(isobutyl)
lA692 RA22 RA14 N(isobutyl)
lA693 RA28 RA14 N(isobutyl)
lA694 H RA22 N(isobutyl)
lA695 RA2 RA22 N(isobutyl)
lA696 RA3 RA22 N(isobutyl)
lA697 RA14 RA22 N(isobutyl)
lA698 RA22 RA22 N(isobutyl)
lA699 RA28 RA22 N(isobutyl)
lA700 H RA28 N(isobutyl)
lA701 RA2 RA28 N(isobutyl)
lA702 RA3 RA28 N(isobutyl)
lA703 RA14 RA28 N(isobutyl)
lA704 RA22 RA28 N(isobutyl)
lA705 RA28 RA28 N(isobutyl)
lA706 RA2 H N(isobutyl)
lA707 RA3 H N(isobutyl)
lA708 RA14 H N(isobutyl)
lA709 RA22 H N(isobutyl)
lA710 RA28 H N(isobutyl)
lA711 RA2 RB1 N(isobutyl)
lA712 RA3 RB1 N(isobutyl)
lA713 RA14 RB1 N(isobutyl)
lA714 RA22 RB1 N(isobutyl)
lA715 RA28 RB1 N(isobutyl)
lA716 RA2 RB2 N(isobutyl)
lA717 RA3 RB2 N(isobutyl)
lA718 RA14 RB2 N(isobutyl)
lA719 RA22 RB2 N(isobutyl)
lA720 RA28 RB2 N(isobutyl)
lA721 RA2 RB3 N(isobutyl)
lA722 RA3 RB3 N(isobutyl)
lA723 RA14 RB3 N(isobutyl)
lA724 RA22 RB3 N(isobutyl)
lA725 RA28 RB3 N(isobutyl)
lA726 RA2 RB4 N(isobutyl)
lA727 RA3 RB4 N(isobutyl)
lA728 RA14 RB4 N(isobutyl)
lA729 RA22 RB4 N(isobutyl)
lA730 RA28 RB4 N(isobutyl)
lA731 RB1 RA2 N(isobutyl)
lA732 RB1 RA3 N(isobutyl)
lA733 RB1 RA14 N(isobutyl)
lA734 RB1 RA22 N(isobutyl)
lA735 RB1 RA28 N(isobutyl)
lA736 RB2 RA2 N(isobutyl)
lA737 RB2 RA3 N(isobutyl)
lA738 RB2 RA14 N(isobutyl)
lA739 RB2 RA22 N(isobutyl)
lA740 RB2 RA28 N(isobutyl)
lA741 RB3 RA2 N(isobutyl)
lA742 RB3 RA3 N(isobutyl)
lA743 RB3 RA14 N(isobutyl)
lA744 RB3 RA22 N(isobutyl)
lA745 RB3 RA28 N(isobutyl)
lA746 RB4 RA2 N(isobutyl)
lA747 RB4 RA3 N(isobutyl)
lA748 RB4 RA14 N(isobutyl)
lA749 RB4 RA22 N(isobutyl)
lA750 RB4 RA28 N(isobutyl)
wherein RB1 to RB4 have the following structures:
##STR00147##
12. The compound of claim 1, wherein the compound has a structure of formula III, (lA)nIr(lB)3-n, wherein lB is a bidentate ligand and n is 1, 2, or 3.
13. The compound of claim 12, wherein the ligand lB is selected from the group consisting of:
##STR00148## ##STR00149## ##STR00150## ##STR00151##
14. The compound of claim 11, wherein the compound is selected from the group consisting of compound 1 through compound 12,750;
wherein each compound x has the formula Ir(lAk)2(lBj);
wherein x=750j+k−750, k is an integer from 1 to 750, and j is an integer from 1 to 17; and
wherein ligands lB1 through lB17 are defined as follows:
##STR00152## ##STR00153## ##STR00154## ##STR00155##
16. The first device of claim 15, wherein the first device is selected from the group consisting of a consumer product, an electronic component module, an organic light-emitting device, and a lighting panel.
17. The first device of claim 15, wherein the organic layer is an emissive layer and the compound is an emissive dopant or a non-emissive dopant.
18. The first device of claim 15, wherein the organic layer further comprises a host, wherein host comprises at least one chemical group selected from the group consisting of carbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene.
19. The first device of claim 15, wherein the organic layer further comprises a host, wherein the host is selected from the group consisting of:
##STR00158## ##STR00159## ##STR00160## ##STR00161## ##STR00162##
and combinations thereof.

This application is a non-provisional U.S. patent application claiming priority, under 35 U.S.C. §119(e)(1), to U.S. Patent Application Ser. No. 62/161,948, filed on May 15, 2015, the entire contents of which are incorporated herein by reference.

The claimed invention was made by, on behalf of, and/or in connection with one or more of the following parties to a joint university corporation research agreement: The Regents of the University of Michigan. Princeton University, University of Southern California, and the Universal Display Corporation. The agreement was in effect on and before the date the claimed invention was made, and the claimed invention was made as a result of activities undertaken within the scope of the agreement.

The present invention relates to compounds for use as emitters, and devices, such as organic light emitting diodes, including the same.

Opto-electronic devices that make use of organic materials are becoming increasingly desirable for a number of reasons. Many of the materials used to make such devices are relatively inexpensive, so organic opto-electronic devices have the potential for cost advantages over inorganic devices. In addition, the inherent properties of organic materials, such as their flexibility, may make them well suited for particular applications such as fabrication on a flexible substrate. Examples of organic opto-electronic devices include organic light emitting diodes/devices (OLEDs), organic phototransistors, organic photovoltaic cells, and organic photodetectors. For OLEDs, the organic materials may have performance advantages over conventional materials. For example, the wavelength at which an organic emissive layer emits light may generally be readily tuned with appropriate dopants.

OLEDs make use of thin organic films that emit light when voltage is applied across the device. OLEDs are becoming an increasingly interesting technology for use in applications such as flat panel displays, illumination, and backlighting. Several OLED materials and configurations are described in U.S. Pat. Nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated herein by reference in their entirety.

One application for phosphorescent emissive molecules is a full color display. Industry standards for such a display call for pixels adapted to emit particular colors, referred to as “saturated” colors. In particular, these standards call for saturated red, green, and blue pixels. Alternatively the OLED can be designed to emit white light. In conventional liquid crystal displays emission from a white backlight is filtered using absorption filters to produce red, green and blue emission. The same technique can also be used with OLEDs. The white OLED can be either a single EML device or a stack structure. Color may be measured using CIE coordinates, which are well known to the art.

One example of a green emissive molecule is tris(2-phenylpyridine) iridium, denoted Ir(ppy)3, which has the following structure:

##STR00001##

In this, and later figures herein, we depict the dative bond from nitrogen to metal (here, Ir) as a straight line.

As used herein, the term “organic” includes polymeric materials as well as small molecule organic materials that may be used to fabricate organic opto-electronic devices. “Small molecule” refers to any organic material that is not a polymer, and “small molecules” may actually be quite large. Small molecules may include repeat units in some circumstances. For example, using a long chain alkyl group as a substituent does not remove a molecule from the “small molecule” class. Small molecules may also be incorporated into polymers, for example as a pendent group on a polymer backbone or as a part of the backbone. Small molecules may also serve as the core moiety of a dendrimer, which consists of a series of chemical shells built on the core moiety. The core moiety of a dendrimer may be a fluorescent or phosphorescent small molecule emitter. A dendrimer may be a “small molecule,” and it is believed that all dendrimers currently used in the field of OLEDs are small molecules.

As used herein, “top” means furthest away from the substrate, while “bottom” means closest to the substrate. Where a first layer is described as “disposed over” a second layer, the first layer is disposed further away from substrate. There may be other layers between the first and second layer, unless it is specified that the first layer is “in contact with” the second layer. For example, a cathode may be described as “disposed over” an anode, even though there are various organic layers in between.

As used herein, “solution processible” means capable of being dissolved, dispersed, or transported in and/or deposited from a liquid medium, either in solution or suspension form.

A ligand may be referred to as “photoactive” when it is believed that the ligand directly contributes to the photoactive properties of an emissive material. A ligand may be referred to as “ancillary” when it is believed that the ligand does not contribute to the photoactive properties of an emissive material, although an ancillary ligand may alter the properties of a photoactive ligand.

As used herein, and as would be generally understood by one skilled in the art, a first “Highest Occupied Molecular Orbital” (HOMO) or “Lowest Unoccupied Molecular Orbital” (LUMO) energy level is “greater than” or “higher than” a second HOMO or LUMO energy level if the first energy level is closer to the vacuum energy level. Since ionization potentials (IP) are measured as a negative energy relative to a vacuum level, a higher HOMO energy level corresponds to an IP having a smaller absolute value (an IP that is less negative). Similarly, a higher LUMO energy level corresponds to an electron affinity (EA) having a smaller absolute value (an EA that is less negative). On a conventional energy level diagram, with the vacuum level at the top, the LUMO energy level of a material is higher than the HOMO energy level of the same material. A “higher” HOMO or LUMO energy level appears closer to the top of such a diagram than a “lower” HOMO or LUMO energy level.

As used herein, and as would be generally understood by one skilled in the art, a first work function is “greater than” or “higher than” a second work function if the first work function has a higher absolute value. Because work functions are generally measured as negative numbers relative to vacuum level, this means that a “higher” work function is more negative. On a conventional energy level diagram, with the vacuum level at the top, a “higher” work function is illustrated as further away from the vacuum level in the downward direction. Thus, the definitions of HOMO and LUMO energy levels follow a different convention than work functions.

More details on OLEDs, and the definitions described above, can be found in U.S. Pat. No. 7,279,704, which is incorporated herein by reference in its entirety.

According to some embodiments of the present disclosure, a compound comprising a ligand LA of Formula I,

##STR00002##

wherein ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring;

wherein R is fused to ring B and has a structure of Formula II:

##STR00003##

wherein the wave lines indicate bonds to ring B;

wherein R1 represents mono, di, tri, or tetra substitution, or no substitution;

wherein R2 represents mono or di substitution, or no substitution;

wherein X1, X2, X3, and X4 are each independently carbon or nitrogen;

wherein at least two adjacent of X1, X2, X3, and X4 are carbon and fuse to R;

wherein X is selected from the group consisting of BR′, NR′, PR′, O, S, Se, C═O, S═O, SO2, CR′R″, SiR′R″, and GeR′R″; wherein R1, R2, R3, R4, R′, and R″ are each independently selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substituents are optionally joined to form into a ring;

wherein at least one of R3 and R4 comprises a chemical group selected from the group consisting of alkyl, cycloalkyl, partially fluorinated alkyl, partially fluorinated cycloalkyl, and combinations thereof;

wherein the ligand LA is coordinated to a metal M;

wherein the ligand LA is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand; and

wherein M is optionally coordinated to other ligands is disclosed.

According to some embodiments, a first OLED comprising an anode, a cathode, and an organic layer, disposed between the anode and the cathode, comprising a compound comprising a ligand LA of Formula I is disclosed.

According to some embodiments, a formulation comprising a compound comprising a ligand LA of Formula I is also disclosed.

FIG. 1 shows an organic light emitting device.

FIG. 2 shows an inverted organic light emitting device that does not have a separate electron transport layer.

Generally, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When a current is applied, the anode injects holes and the cathode injects electrons into the organic layer(s). The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and hole localize on the same molecule, an “exciton,” which is a localized electron-hole pair having an excited energy state, is formed. Light is emitted when the exciton relaxes via a photoemissive mechanism. In some cases, the exciton may be localized on an excimer or an exciplex. Non-radiative mechanisms, such as thermal relaxation, may also occur, but are generally considered undesirable.

The initial OLEDs used emissive molecules that emitted light from their singlet states (“fluorescence”) as disclosed, for example, in U.S. Pat. No. 4,769,292, which is incorporated by reference in its entirety. Fluorescent emission generally occurs in a time frame of less than 10 nanoseconds.

More recently. OLEDs having emissive materials that emit light from triplet states (“phosphorescence”) have been demonstrated. Baldo et al., “Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices,” Nature, vol. 395, 151-154, 1998; (“Baldo-I”) and Baldo et al., “Very high-efficiency green organic light-emitting devices based on electrophosphorescence.” Appl. Phys. Lett., vol. 75, No. 3, 4-6 (1999) (“Baldo-II”), are incorporated by reference in their entireties. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704 at cols. 5-6, which are incorporated by reference.

FIG. 1 shows an organic light emitting device 100. The figures are not necessarily drawn to scale. Device 100 may include a substrate 110, an anode 115, a hole injection layer 120, a hole transport layer 125, an electron blocking layer 130, an emissive layer 135, a hole blocking layer 140, an electron transport layer 145, an electron injection layer 150, a protective layer 155, a cathode 160, and a barrier layer 170. Cathode 160 is a compound cathode having a first conductive layer 162 and a second conductive layer 164. Device 100 may be fabricated by depositing the layers described, in order. The properties and functions of these various layers, as well as example materials, are described in more detail in U.S. Pat. No. 7,279,704 at cols. 6-10, which are incorporated by reference.

More examples for each of these layers are available. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is m-MTDATA doped with F4-TCNQ at a molar ratio of 50:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirely. Examples of emissive and host materials are disclosed in U.S. Pat. No. 6,303,238 to Thompson et al., which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entireties, disclose examples of cathodes including compound cathodes having a thin layer of metal such as Mg:Ag with an overlying transparent, electrically-conductive, sputter-deposited ITO layer. The theory and use of blocking layers is described in more detail in U.S. Pat. No. 6,097,147 and U.S. Patent Application Publication No. 2003/0230980, which are incorporated by reference in their entireties. Examples of injection layers are provided in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of protective layers may be found in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety.

FIG. 2 shows an inverted OLED 200. The device includes a substrate 210, a cathode 215, an emissive layer 220, a hole transport layer 225, and an anode 230. Device 200 may be fabricated by depositing the layers described, in order. Because the most common OLED configuration has a cathode disposed over the anode, and device 200 has cathode 215 disposed under anode 230, device 200 may be referred to as an “inverted” OLED. Materials similar to those described with respect to device 100 may be used in the corresponding layers of device 200. FIG. 2 provides one example of how some layers may be omitted from the structure of device 100.

The simple layered structure illustrated in FIGS. 1 and 2 is provided by way of non-limiting example, and it is understood that embodiments of the invention may be used in connection with a wide variety of other structures. The specific materials and structures described are exemplary in nature, and other materials and structures may be used. Functional OLEDs may be achieved by combining the various layers described in different ways, or layers may be omitted entirely, based on design, performance, and cost factors. Other layers not specifically described may also be included. Materials other than those specifically described may be used. Although many of the examples provided herein describe various layers as comprising a single material, it is understood that combinations of materials, such as a mixture of host and dopant, or more generally a mixture, may be used. Also, the layers may have various sublayers. The names given to the various layers herein are not intended to be strictly limiting. For example, in device 200, hole transport layer 225 transports holes and injects holes into emissive layer 220, and may be described as a hole transport layer or a hole injection layer. In one embodiment, an OLED may be described as having an “organic layer” disposed between a cathode and an anode. This organic layer may comprise a single layer, or may further comprise multiple layers of different organic materials as described, for example, with respect to FIGS. 1 and 2.

Structures and materials not specifically described may also be used, such as OLEDs comprised of polymeric materials (PLEDs) such as disclosed in U.S. Pat. No. 5,247,190 to Friend et al., which is incorporated by reference in its entirety. By way of further example, OLEDs having a single organic layer may be used. OLEDs may be stacked, for example as described in U.S. Pat. No. 5,707,745 to Forrest et al. which is incorporated by reference in its entirety. The OLED structure may deviate from the simple layered structure illustrated in FIGS. 1 and 2. For example, the substrate may include an angled reflective surface to improve out-coupling, such as a mesa structure as described in U.S. Pat. No. 6,091,195 to Forrest et al., and/or a pit structure as described in U.S. Pat. No. 5,834,893 to Bulovic et al., which are incorporated by reference in their entireties.

Unless otherwise specified, any of the layers of the various embodiments may be deposited by any suitable method. For the organic layers, preferred methods include thermal evaporation, ink-jet, such as described in U.S. Pat. Nos. 6,013,982 and 6,087,196, which are incorporated by reference in their entireties, organic vapor phase deposition (OVPD), such as described in U.S. Pat. No. 6,337,102 to Forrest et al., which is incorporated by reference in its entirety, and deposition by organic vapor jet printing (OVJP), such as described in U.S. Pat. No. 7,431,968, which is incorporated by reference in its entirety. Other suitable deposition methods include spin coating and other solution based processes. Solution based processes are preferably carried out in nitrogen or an inert atmosphere. For the other layers, preferred methods include thermal evaporation. Preferred patterning methods include deposition through a mask, cold welding such as described in U.S. Pat. Nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entireties, and patterning associated with some of the deposition methods such as ink jet and OVJD. Other methods may also be used. The materials to be deposited may be modified to make them compatible with a particular deposition method. For example, substituents such as alkyl and aryl groups, branched or unbranched, and preferably containing at least 3 carbons, may be used in small molecules to enhance their ability to undergo solution processing. Substituents having 20 carbons or more may be used, and 3-20 carbons is a preferred range. Materials with asymmetric structures may have better solution processability than those having symmetric structures, because asymmetric materials may have a lower tendency to recrystallize. Dendrimer substituents may be used to enhance the ability of small molecules to undergo solution processing.

Devices fabricated in accordance with embodiments of the present invention may further optionally comprise a barrier layer. One purpose of the barrier layer is to protect the electrodes and organic layers from damaging exposure to harmful species in the environment including moisture, vapor and/or gases, etc. The barrier layer may be deposited over, under or next to a substrate, an electrode, or over any other parts of a device including an edge. The barrier layer may comprise a single layer, or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include compositions having a single phase as well as compositions having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate an inorganic or an organic compound or both. The preferred barrier layer comprises a mixture of a polymeric material and a non-polymeric material as described in U.S. Pat. No. 7,968,146. PCT Pat. Application Nos. PCT/US2007/023098 and PCT/US2009/042829, which are herein incorporated by reference in their entireties. To be considered a “mixture”, the aforesaid polymeric and non-polymeric materials comprising the barrier layer should be deposited under the same reaction conditions and/or at the same time. The weight ratio of polymeric to non-polymeric material may be in the range of 95:5 to 5:95. The polymeric material and the non-polymeric material may be created from the same precursor material. In one example, the mixture of a polymeric material and a non-polymeric material consists essentially of polymeric silicon and inorganic silicon.

Devices fabricated in accordance with embodiments of the invention can be incorporated into a wide variety of electronic component modules (or units) that can be incorporated into a variety of electronic products or intermediate components. Examples of such electronic products or intermediate components include display screens, lighting devices such as discrete light source devices or lighting panels, etc. that can be utilized by the end-user product manufacturers. Such electronic component modules can optionally include the driving electronics and/or power source(s). Devices fabricated in accordance with embodiments of the invention can be incorporated into a wide variety of consumer products that have one or more of the electronic component modules (or units) incorporated therein. Such consumer products would include any kind of products that include one or more light source(s) and/or one or more of some type of visual displays. Some examples of such consumer products include flat panel displays, computer monitors, medical monitors, televisions, billboards, lights for interior or exterior illumination and/or signaling, heads-up displays, fully or partially transparent displays, flexible displays, laser printers, telephones, cell phones, tablets, phablets, personal digital assistants (PDAs), wearable device, laptop computers, digital cameras, camcorders, viewfinders, micro-displays, 3-D displays, vehicles, a large area wall, theater or stadium screen, or a sign. Various control mechanisms may be used to control devices fabricated in accordance with the present invention, including passive matrix and active matrix. Many of the devices are intended for use in a temperature range comfortable to humans, such as 18 degrees C. to 30 degrees C., and more preferably at room temperature (20-25 degrees C.), but could be used outside this temperature range, for example, from −40 degree C. to +80 degree C.

The materials and structures described herein may have applications in devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may employ the materials and structures. More generally, organic devices, such as organic transistors, may employ the materials and structures.

The term “halo,” “halogen,” or “halide” as used herein includes fluorine, chlorine, bromine, and iodine.

The term “alkyl” as used herein contemplates both straight and branched chain alkyl radicals. Preferred alkyl groups are those containing from one to fifteen carbon atoms and includes methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, and the like. Additionally, the alkyl group may be optionally substituted.

The term “cycloalkyl” as used herein contemplates cyclic alkyl radicals. Preferred cycloalkyl groups are those containing 3 to 10 ring carbon atoms and includes cyclopropyl, cyclopentyl, cyclohexyl, adamantyl, and the like. Additionally, the cycloalkyl group may be optionally substituted.

The term “alkenyl” as used herein contemplates both straight and branched chain alkene radicals. Preferred alkenyl groups are those containing two to fifteen carbon atoms. Additionally, the alkenyl group may be optionally substituted.

The term “alkynyl” as used herein contemplates both straight and branched chain alkyne radicals. Preferred alkynyl groups are those containing two to fifteen carbon atoms. Additionally, the alkynyl group may be optionally substituted.

The terms “aralkyl” or “arylalkyl” as used herein are used interchangeably and contemplate an alkyl group that has as a substituent an aromatic group. Additionally, the aralkyl group may be optionally substituted.

The term “heterocyclic group” as used herein contemplates aromatic and non-aromatic cyclic radicals. Hetero-aromatic cyclic radicals also means heteroaryl. Preferred hetero-non-aromatic cyclic groups are those containing 3 or 7 ring atoms which includes at least one hetero atom, and includes cyclic amines such as morpholino, piperdino, pyrrolidino, and the like, and cyclic ethers, such as tetrahydrofuran, tetrahydropyran, and the like. Additionally, the heterocyclic group may be optionally substituted.

The term “aryl” or “aromatic group” as used herein contemplates single-ring groups and polycyclic ring systems. The polycyclic rings may have two or more rings in which two carbons are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is aromatic, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. Preferred aryl groups are those containing six to thirty carbon atoms, preferably six to twenty carbon atoms, more preferably six to twelve carbon atoms. Especially preferred is an aryl group having six carbons, ten carbons or twelve carbons. Suitable aryl groups include phenyl, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene, preferably phenyl, biphenyl, triphenyl, triphenylene, fluorene, and naphthalene. Additionally, the aryl group may be optionally substituted.

The term “heteroaryl” as used herein contemplates single-ring hetero-aromatic groups that may include from one to five heteroatoms. The term heteroaryl also includes polycyclic hetero-aromatic systems having two or more rings in which two atoms are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is a heteroaryl. e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. Preferred heteroaryl groups are those containing three to thirty carbon atoms, preferably three to twenty carbon atoms, more preferably three to twelve carbon atoms. Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine, preferably dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, triazine, benzimidazole, and aza-analogs thereof. Additionally, the heteroaryl group may be optionally substituted.

The alkyl, cycloalkyl, alkenyl, alkynyl, aralkyl, heterocyclic group, aryl, and heteroaryl may be unsubstituted or may be substituted with one or more substituents selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, cyclic amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

As used herein, “substituted” indicates that a substituent other than H is bonded to the relevant position, such as carbon. Thus, for example, where R1 is mono-substituted, then one R1 must be other than H. Similarly, where R1 is di-substituted, then two of R1 must be other than H. Similarly, where R1 is unsubstituted. R1 is hydrogen for all available positions.

The “aza” designation in the fragments described herein, i.e. aza-dibenzofuran, aza-dibenzothiophene, etc. means that one or more of the C—H groups in the respective fragment can be replaced by a nitrogen atom, for example, and without any limitation, azatriphenylene encompasses both dibenzo[f,h]quinoxaline and dibenzo[f,h]quinoline. One of ordinary skill in the art can readily envision other nitrogen analogs of the aza-derivatives described above, and all such analogs are intended to be encompassed by the terms as set forth herein.

It is to be understood that when a molecular fragment is described as being a substituent or otherwise attached to another moiety, its name may be written as if it were a fragment (e.g. phenyl, phenylene, naphthyl, dibenzofuryl) or as if it were the whole molecule (e.g. benzene, naphthalene, dibenzofuran). As used herein, these different ways of designating a substituent or attached fragment are considered to be equivalent.

According to an aspect of the present disclosure, ligands containing five-membered ring fused on pyridine or pyrimidine ring combined with partially fluorinated side chains that are found to be useful as phosphorescent light-emitting metal complexes for organic light emitting devices are disclosed. The resulting light-emitting metal complexes exhibited improved external quantum efficiency and lifetimes.

Some exemplary ligands disclosed herein are fluoropyrimidine, thienopyrimidine, pyrrolopyrimidine, and cyclopentapyrimidine. In some embodiments, these ligands can be combined with aliphatic substituents containing at least one F atom. The combination of these two moieties on a single ligand was used for multiple reasons. Pyridine- or pyrimidine-based ligands used for red dopants have shown very good device efficiency and good lifetime. The incorporation of one or multiple side chains containing F atom will allow fine tuning of the color and especially provide a red shift.

According to some embodiments, a compound comprising a ligand LA of Formula I,

##STR00004##
is disclosed; wherein ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring:

wherein R is fused to ring B and has a structure of Formula II,

##STR00005##
wherein the wave lines indicate bonds to ring B;

wherein R1 represents mono, di, tri, or tetra substitution, or no substitution;

wherein R2 represents mono or di substitution, or no substitution;

wherein X1, X2, X3, and X4 are each independently carbon or nitrogen;

wherein at least two adjacent of X1, X2, X3, and X4 are carbon and fuse to R;

wherein X is selected from the group consisting of BR′, NR′, PR′, O, S, Sc, C═O, S═O, SO2, CR′R″, SiR′R″, and GeR′R″;

wherein R1, R2, R3, R4, R′, and R″ are each independently selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substituents are optionally joined to form into a ring;

wherein at least one of R1 and R4 comprises a chemical group selected from the group consisting of alkyl, cycloalkyl, partially fluorinated alkyl, partially fluorinated cycloalkyl, and combinations thereof;

wherein the ligand LA is coordinated to a metal M;

wherein the ligand LA is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand, and wherein M is optionally coordinated to other ligands.

In some embodiments of the compound, M is selected from the group consisting of Ir, Rh, Re, Ru, Os, Pt, Au, and Cu.

In some embodiments of the compound, M is Ir or Pt.

In some embodiments of the compound, the ligand LA is selected from the group consisting of:

##STR00006## ##STR00007##

In some embodiments of the compound, the ligand LA is:

##STR00008##

In some embodiments of the compound, the ligand LA is:

##STR00009##

In some embodiments of the compound, at least one of R3 and R4 is a chemical group selected from the group consisting of alkyl, cycloalkyl, partially fluorinated alkyl, partially fluorinated cycloalkyl, and combinations thereof.

In some embodiments of the compound, at least one of R3 and R4 is a chemical group selected from the group consisting of partially fluorinated alkyl, partially fluorinated cycloalkyl, and combinations thereof.

In some embodiments of the compound, R3 and R4 are not hydrogen.

In some embodiments of the compound, at least one of X1, X2, X3, and X4 is nitrogen.

In some embodiments of the compound, X is O.

In some embodiments of the compound, X is NR′.

In some embodiments of the compound, X is CR′R″ or SiR′R″.

In some embodiments of the compound. R1, R2, R3, R4, R′ and R″ are each independently selected from the group consisting of hydrogen, deuterium, alkyl, cycloalkyl, and combinations thereof.

In some embodiments of the compound, R1, R2, R3, R4, R′ and R″ are each independently selected from the group consisting of hydrogen, deuterium, methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, cyclopentyl, cyclohexyl, and combinations thereof.

In some embodiments of the compound, at least one of R3 and R4 is selected from the group consisting of:

##STR00010## ##STR00011## ##STR00012##

In some embodiments of the compound, R3 and R4 are joined to form a ring structure selected from the group consisting of:

##STR00013## ##STR00014##

In some embodiments of the compound, at least one of R3 and R4 is selected from the group consisting of:

##STR00015##

In some embodiments of the compound, the ligand LA is selected from the group consisting of:

##STR00016##
wherein R1, R2, R3, and R′ are as defined above.

In some embodiments of the compound, the ligand LA is selected from the group consisting of LA1 through LA750 defined as follows:

LA1 through LA375 are based on a structure of Formula IV,

##STR00017##
in which R3, R4, and X are defined as shown in Table 1 below:

TABLE 1
Ligand R3 R4 X
LA1 H RA2 O
LA2 RA2 RA2 O
LA3 RA3 RA2 O
LA4 RA14 RA2 O
LA5 RA22 RA2 O
LA6 RA28 RA2 O
LA7 H RA3 O
LA8 RA2 RA3 O
LA9 RA3 RA3 O
LA10 RA14 RA3 O
LA11 RA22 RA3 O
LA12 RA28 RA3 O
LA13 H RA14 O
LA14 RA2 RA14 O
LA15 RA3 RA14 O
LA16 RA14 RA14 O
LA17 RA22 RA14 O
LA18 RA28 RA14 O
LA19 H RA22 O
LA20 RA2 RA22 O
LA21 RA3 RA22 O
LA22 RA14 RA22 O
LA23 RA22 RA22 O
LA24 RA28 RA22 O
LA25 H RA28 O
LA26 RA2 RA28 O
LA27 RA3 RA28 O
LA28 RA14 RA28 O
LA29 RA22 RA28 O
LA30 RA28 RA28 O
LA31 RA2 H O
LA32 RA3 H O
LA33 RA14 H O
LA34 RA22 H O
LA35 RA28 H O
LA36 RA2 RB1 O
LA37 RA3 RB1 O
LA38 RA14 RB1 O
LA39 RA12 RB1 O
LA40 RA28 RB1 O
LA41 RA2 RB2 O
LA42 RA3 RB2 O
LA43 RA14 RB2 O
LA44 RA22 RB2 O
LA45 RA28 RB2 O
LA46 RA2 RB3 O
LA47 RA3 RB3 O
LA48 RA14 RB3 O
LA49 RA22 RB3 O
LA50 RA28 RB3 O
LA51 RA2 RB4 O
LA52 RA3 RB4 O
LA53 RA14 RB4 O
LA54 RA22 RB4 O
LA55 RA28 RB4 O
LA56 RB1 RA2 O
LA57 RB1 RA3 O
LA58 RB1 RA14 O
LA59 RB1 RA22 O
LA60 RB1 RA28 O
LA61 RB2 RA2 O
LA62 RB2 RA3 O
LA63 RB2 RA14 O
LA64 RB2 RA22 O
LA65 RB2 RA28 O
LA66 RB3 RA2 O
LA67 RB3 RA3 O
LA68 RB3 RA14 O
LA69 RB3 RA22 O
LA70 RB3 RA28 O
LA71 RB4 RA2 O
LA72 RB4 RA3 O
LA73 RB4 RA14 O
LA74 RB4 RA22 O
LA75 RB4 RA28 O
LA76 H RA2 S
LA77 RA2 RA2 S
LA78 RA3 RA2 S
LA79 RA14 RA2 S
LA80 RA22 RA2 S
LA81 RA28 RA2 S
LA82 H RA3 S
LA83 RA2 RA3 S
LA84 RA3 RA3 S
LA85 RA14 RA3 S
LA86 RA22 RA3 S
LA87 RA28 RA3 S
LA88 H RA14 S
LA89 RA2 RA14 S
LA90 RA3 RA14 S
LA91 RA14 RA14 S
LA92 RA22 RA14 S
LA93 RA28 RA14 S
LA94 H RA22 S
LA95 RA2 RA22 S
LA96 RA3 RA22 S
LA97 RA14 RA22 S
LA98 RA22 RA22 S
LA99 RA28 RA22 S
LA100 H RA28 S
LA101 RA2 RA28 S
LA102 RA3 RA28 S
LA103 RA14 RA28 S
LA104 RA22 RA28 S
LA105 RA28 RA28 S
LA106 RA2 H S
LA107 RA3 H S
LA108 RA14 H S
LA109 RA22 H S
LA110 RA28 H S
LA111 RA2 RB1 S
LA112 RA3 RB1 S
LA113 RA14 RB1 S
LA114 RA22 RB1 S
LA115 RA28 RB1 S
LA116 RA2 RB2 S
LA117 RA3 RB2 S
LA118 RA14 RB2 S
LA119 RA22 RB2 S
LA120 RA28 RB2 S
LA121 RA2 RB3 S
LA122 RA3 RB3 S
LA123 RA14 RB3 S
LA124 RA22 RB3 S
LA125 RA28 RB3 S
LA126 RA2 RB4 S
LA127 RA3 RB4 S
LA128 RA14 RB4 S
LA129 RA22 RB4 S
LA130 RA28 RB4 S
LA131 RB1 RA2 S
LA132 RB1 RA3 S
LA133 RB1 RA14 S
LA134 RB1 RA22 S
LA135 RB1 RA28 S
LA136 RB2 RA2 S
LA137 RB2 RA3 S
LA138 RB2 RA14 S
LA139 RB2 RA22 S
LA140 RB2 RA28 S
LA141 RB3 RA2 S
LA142 RB3 RA3 S
LA143 RB3 RA14 S
LA144 RB3 RA22 S
LA145 RB3 RA28 S
LA146 RB4 RA2 S
LA147 RB4 RA3 S
LA148 RB4 RA14 S
LA149 RB4 RA22 S
LA150 RB4 RA28 S
LA151 H RA2 C(CH3)2
LA152 RA2 RA2 C(CH3)2
LA153 RA3 RA2 C(CH3)2
LA154 RA14 RA2 C(CH3)2
LA155 RA22 RA2 C(CH3)2
LA156 RA28 RA2 C(CH3)2
LA157 H RA3 C(CH3)2
LA158 RA2 RA3 C(CH3)2
LA159 RA3 RA3 C(CH3)2
LA160 RA14 RA3 C(CH3)2
LA161 RA22 RA3 C(CH3)2
LA162 RA28 RA3 C(CH3)2
LA163 H RA14 C(CH3)2
LA164 RA2 RA14 C(CH3)2
LA165 RA3 RA14 C(CH3)2
LA166 RA14 RA14 C(CH3)2
LA167 RA22 RA14 C(CH3)2
LA168 RA28 RA14 C(CH3)2
LA169 H RA22 C(CH3)2
LA170 RA2 RA22 C(CH3)2
LA171 RA3 RA22 C(CH3)2
LA172 RA14 RA22 C(CH3)2
LA173 RA22 RA22 C(CH3)2
LA174 RA28 RA22 C(CH3)2
LA175 H RA28 C(CH3)2
LA176 RA2 RA28 C(CH3)2
LA177 RA3 RA28 C(CH3)2
LA178 RA14 RA28 C(CH3)2
LA179 RA22 RA28 C(CH3)2
LA180 RA28 RA28 C(CH3)2
LA181 RA2 H C(CH3)2
LA182 RA3 H C(CH3)2
LA183 RA14 H C(CH3)2
LA184 RA22 H C(CH3)2
LA185 RA28 H C(CH3)2
LA186 RA2 RB1 C(CH3)2
LA187 RA3 RB1 C(CH3)2
LA188 RA14 RB1 C(CH3)2
LA189 RA22 RB1 C(CH3)2
LA190 RA28 RB1 C(CH3)2
LA191 RA2 RB2 C(CH3)2
LA192 RA3 RB2 C(CH3)2
LA193 RA14 RB2 C(CH3)2
LA194 RA22 RB2 C(CH3)2
LA195 RA28 RB2 C(CH3)2
LA196 RA2 RB3 C(CH3)2
LA197 RA3 RB3 C(CH3)2
LA198 RA14 RB3 C(CH3)2
LA199 RA22 RB3 C(CH3)2
LA200 RA28 RB3 C(CH3)2
LA201 RA2 RB4 C(CH3)2
LA202 RA3 RB4 C(CH3)2
LA203 RA14 RB4 C(CH3)2
LA204 RA22 RB4 C(CH3)2
LA205 RA28 RB4 C(CH3)2
LA206 RB1 RA2 C(CH3)2
LA207 RB1 RA3 C(CH3)2
LA208 RB1 RA14 C(CH3)2
LA209 RB1 RA22 C(CH3)2
LA210 RB1 RA28 C(CH3)2
LA211 RB2 RA2 C(CH3)2
LA212 RB2 RA3 C(CH3)2
LA213 RB2 RA14 C(CH3)2
LA214 RB2 RA22 C(CH3)2
LA215 RB2 RA28 C(CH3)2
LA216 RB3 RA2 C(CH3)2
LA217 RB3 RA3 C(CH3)2
LA218 RB3 RA14 C(CH3)2
LA219 RB3 RA22 C(CH3)2
LA220 RB3 RA28 C(CH3)2
LA221 RB4 RA2 C(CH3)2
LA222 RB4 RA3 C(CH3)2
LA223 RB4 RA14 C(CH3)2
LA224 RB4 RA22 C(CH3)2
LA225 RB4 RA28 C(CH3)2
LA226 H RA2 NCH3
LA227 RA2 RA2 NCH3
LA228 RA3 RA2 NCH3
LA229 RA14 RA2 NCH3
LA230 RA22 RA2 NCH3
LA231 RA28 RA2 NCH3
LA232 H RA3 NCH3
LA233 RA2 RA3 NCH3
LA234 RA3 RA3 NCH3
LA235 RA14 RA3 NCH3
LA236 RA22 RA3 NCH3
LA237 RA28 RA3 NCH3
LA238 H RA14 NCH3
LA239 RA2 RA14 NCH3
LA240 RA3 RA14 NCH3
LA241 RA14 RA14 NCH3
LA242 RA22 RA14 NCH3
LA243 RA28 RA14 NCH3
LA244 H RA22 NCH3
LA245 RA2 RA22 NCH3
LA246 RA3 RA22 NCH3
LA247 RA14 RA22 NCH3
LA248 RA22 RA22 NCH3
LA249 RA28 RA22 NCH3
LA250 H RA28 NCH3
LA251 RA2 RA28 NCH3
LA252 RA3 RA28 NCH3
LA253 RA14 RA28 NCH3
LA254 RA22 RA28 NCH3
LA255 RA28 RA28 NCH3
LA256 RA2 H NCH3
LA257 RA3 H NCH3
LA258 RA14 H NCH3
LA259 RA22 H NCH3
LA260 RA28 H NCH3
LA261 RA2 RB1 NCH3
LA262 RA3 RB1 NCH3
LA263 RA14 RB1 NCH3
LA264 RA22 RBI NCH3
LA265 RA28 RB1 NCH3
LA266 RA2 RB2 NCH3
LA267 RA3 RB2 NCH3
LA268 RA14 RB2 NCH3
LA269 RA22 RB2 NCH3
LA270 RA28 RB2 NCH3
LA271 RA2 RB3 NCH3
LA272 RA3 RB3 NCH3
LA273 RA14 RB3 NCH3
LA274 RA22 RB3 NCH3
LA275 RA28 RB3 NCH3
LA276 RA2 RB4 NCH3
LA277 RA3 RB4 NCH3
LA278 RA14 RB4 NCH3
LA279 RA22 RB4 NCH3
LA280 RA28 RB4 NCH3
LA281 RA2 RB1 NCH3
LA282 RA3 RB1 NCH3
LA283 RA14 RB1 NCH3
LA284 RA22 RB1 NCH3
LA285 RA28 RB1 NCH3
LA286 RA2 RB2 NCH3
LA287 RA3 RB2 NCH3
LA288 RA14 RB2 NCH3
LA289 RA22 RB2 NCH3
LA290 RA28 RB2 NCH3
LA291 RA2 RB3 NCH3
LA292 RA3 RB3 NCH3
LA293 RA14 RB3 NCH3
LA294 RA22 RB3 NCH3
LA295 RA28 RB3 NCH3
LA296 RA2 RB4 NCH3
LA297 RA3 RB4 NCH3
LA298 RA14 RB4 NCH3
LA299 RA22 RB4 NCH3
LA300 RA28 RB4 NCH3
LA301 H RA2 N(isobutyl)
LA302 RA2 RA2 N(isobutyl)
LA303 RA3 RA2 N(isobutyl)
LA304 RA14 RA2 N(isobutyl)
LA305 RA22 RA2 N(isobutyl)
LA306 RA28 RA2 N(isobutyl)
LA307 H RA3 N(isobutyl)
LA308 RA2 RA3 N(isobutyl)
LA309 RA3 RA3 N(isobutyl)
LA310 RA14 RA3 N(isobutyl)
LA311 RA22 RA3 N(isobutyl)
LA312 RA28 RA3 N(isobutyl)
LA313 H RA14 N(isobutyl)
LA314 RA2 RA14 N(isobutyl)
LA315 RA3 RA14 N(isobutyl)
LA316 RA14 RA14 N(isobutyl)
LA317 RA22 RA14 N(isobutyl)
LA318 RA28 RA14 N(isobutyl)
LA319 H RA22 N(isobutyl)
LA320 RA2 RA22 N(isobutyl)
LA321 RA3 RA22 N(isobutyl)
LA322 RA14 RA22 N(isobutyl)
LA323 RA22 RA22 N(isobutyl)
LA324 RA28 RA22 N(isobutyl)
LA325 H RA28 N(isobutyl)
LA326 RA2 RA28 N(isobutyl)
LA327 RA3 RA28 N(isobutyl)
LA328 RA14 RA28 N(isobutyl)
LA329 RA22 RA28 N(isobutyl)
LA330 RA28 RA28 N(isobutyl)
LA331 RA2 H N(isobutyl)
LA332 RA3 H N(isobutyl)
LA333 RA14 H N(isobutyl)
LA334 RA22 H N(isobutyl)
LA335 RA28 H N(isobutyl)
LA336 RA2 RB1 N(isobutyl)
LA337 RA3 RB1 N(isobutyl)
LA338 RA14 RB1 N(isobutyl)
LA339 RA22 RB1 N(isobutyl)
LA340 RA28 RB1 N(isobutyl)
LA341 RA2 RB2 N(isobutyl)
LA342 RA3 RB2 N(isobutyl)
LA343 RA14 RB2 N(isobutyl)
LA344 RA22 RB2 N(isobutyl)
LA345 RA28 RB2 N(isobutyl)
LA346 RA2 RB3 N(isobutyl)
LA347 RA3 RB3 N(isobutyl)
LA348 RA14 RB3 N(isobutyl)
LA349 RA22 RB3 N(isobutyl)
LA350 RA28 RB3 N(isobutyl)
LA351 RA2 RB4 N(isobutyl)
LA352 RA3 RB4 N(isobutyl)
LA353 RA14 RB4 N(isobutyl)
LA354 RA22 RB4 N(isobutyl)
LA355 RA28 RB4 N(isobutyl)
LA356 RB1 RA2 N(isobutyl)
LA357 RB1 RA3 N(isobutyl)
LA358 RB1 RA14 N(isobutyl)
LA359 RB1 RA22 N(isobutyl)
LA360 RB1 RA28 N(isobutyl)
LA361 RB2 RA2 N(isobutyl)
LA362 RB2 RA3 N(isobutyl)
LA363 RB2 RA14 N(isobutyl)
LA364 RB2 RA22 N(isobutyl)
LA365 RB2 RA28 N(isobutyl)
LA366 RB3 RA2 N(isobutyl)
LA367 RB3 RA3 N(isobutyl)
LA368 RB3 RA14 N(isobutyl)
LA369 RB3 RA22 N(isobutyl)
LA370 RB3 RA28 N(isobutyl)
LA371 RB4 RA2 N(isobutyl)
LA372 RB4 RA3 N(isobutyl)
LA373 RB4 RA14 N(isobutyl)
LA374 RB4 RA22 N(isobutyl)
LA375 RB4 RA28 N(isobutyl)

and LA376 through LA750 are based on a structure of, Formula V,

##STR00018##
in which R3, R4, and X are defined as shown in Table 2 below:

TABLE 2
Ligand R3 R4 X
LA376 H RA2 O
LA377 RA2 RA2 O
LA378 RA3 RA2 O
LA379 RA14 RA2 O
LA380 RA22 RA2 O
LA381 RA28 RA2 O
LA382 H RA3 O
LA383 RA2 RA3 O
LA384 RA3 RA3 O
LA385 RA14 RA3 O
LA386 RA22 RA3 O
LA387 RA28 RA3 O
LA388 H RA14 O
LA389 RA2 RA14 O
LA390 RA3 RA14 O
LA391 RA14 RA14 O
LA392 RA22 RA14 O
LA393 RA28 RA14 O
LA394 H RA22 O
LA395 RA2 RA22 O
LA396 RA3 RA22 O
LA397 RA14 RA22 O
LA398 RA22 RA22 O
LA399 RA28 RA22 O
LA400 H RA28 O
LA401 RA2 RA28 O
LA402 RA3 RA28 O
LA403 RA14 RA28 O
LA404 RA22 RA28 O
LA405 RA28 RA28 O
LA406 RA2 H O
LA407 RA3 H O
LA408 RA14 H O
LA409 RA22 H O
LA410 RA28 H O
LA411 RA2 RB1 O
LA412 RA3 RB1 O
LA413 RA14 RB1 O
LA414 RA22 RB1 O
LA415 RA28 RB1 O
LA416 RA2 RB2 O
LA417 RA3 RB2 O
LA418 RA14 RB2 O
LA419 RA22 RB2 O
LA420 RA28 RB2 O
LA421 RA2 RB3 O
LA422 RA3 RB3 O
LA423 RA14 RB3 O
LA424 RA22 RB3 O
LA425 RA28 RB3 O
LA426 RA2 RB4 O
LA427 RA3 RB4 O
LA428 RA14 RB4 O
LA429 RA22 RB4 O
LA430 RA28 RB4 O
LA431 RB1 RA2 O
LA432 RB1 RA3 O
LA433 RB1 RA14 O
LA434 RB1 RA22 O
LA435 RB1 RA28 O
LA436 RB2 RA2 O
LA437 RB2 RA3 O
LA438 RB2 RA14 O
LA439 RB2 RA22 O
LA440 RB2 RA28 O
LA441 RB3 RA2 O
LA442 RB3 RA3 O
LA443 RB3 RA14 O
LA444 RB3 RA22 O
LA445 RB3 RA28 O
LA446 RB4 RA2 O
LA447 RB4 RA3 O
LA448 RB4 RA14 O
LA449 RB4 RA22 O
LA450 RB4 RA28 O
LA451 H RA2 S
LA452 RA2 RA2 S
LA453 RA3 RA2 S
LA454 RA14 RA2 S
LA455 RA22 RA2 S
LA456 RA28 RA2 S
LA457 H RA3 S
LA458 RA2 RA3 S
LA459 RA3 RA3 S
LA460 RA14 RA3 S
LA461 RA22 RA3 S
LA462 RA28 RA3 S
LA463 H RA14 S
LA464 RA2 RA14 S
LA465 RA3 RA14 S
LA466 RA14 RA14 S
LA467 RA22 RA14 S
LA468 RA28 RA14 S
LA469 H RA22 S
LA470 RA2 RA22 S
LA471 RA3 RA22 S
LA472 RA14 RA22 S
LA473 RA22 RA22 S
LA474 RA28 RA22 S
LA475 H RA28 S
LA476 RA2 RA28 S
LA477 RA3 RA28 S
LA478 RA14 RA28 S
LA479 RA22 RA28 S
LA480 RA28 RA28 S
LA481 RA2 H S
LA482 RA3 H S
LA483 RA14 H S
LA484 RA22 H S
LA485 RA28 H S
LA486 RA2 RB1 S
LA487 RA3 RB1 S
LA488 RA14 RB1 S
LA489 RA22 RB1 S
LA490 RA28 RB1 S
LA491 RA2 RB2 S
LA492 RA3 RB2 S
LA493 RA14 RB2 S
LA494 RA22 RB2 S
LA495 RA28 RB2 S
LA496 RA2 RB3 S
LA497 RA3 RB3 S
LA498 RA14 RB3 S
LA499 RA22 RB3 S
LA500 RA28 RB3 S
LA501 RA2 RB4 S
LA502 RA3 RB4 S
LA503 RA14 RB4 S
LA504 RA22 RB4 S
LA505 RA28 RB4 S
LA506 RB1 RA2 S
LA507 RB1 RA3 S
LA508 RB1 RA14 S
LA509 RB1 RA22 S
LA510 RB1 RA28 S
LA511 RB2 RA2 S
LA512 RB2 RA3 S
LA513 RB2 RA14 S
LA514 RB2 RA22 S
LA515 RB2 RA28 S
LA516 RB3 RA2 S
LA517 RB3 RA3 S
LA518 RB3 RA14 S
LA519 RB3 RA22 S
LA520 RB3 RA28 S
LA521 RB4 RA2 S
LA522 RB4 RA3 S
LA523 RB4 RA14 S
LA524 RB4 RA22 S
LA525 RB4 RA28 S
LA526 H RA2 C(CH3)2
LA527 RA2 RA2 C(CH3)2
LA528 RA3 RA2 C(CH3)2
LA529 RA14 RA2 C(CH3)2
LA530 RA22 RA2 C(CH3)2
LA531 RA28 RA2 C(CH3)2
LA532 H RA3 C(CH3)2
LA533 RA2 RA3 C(CH3)2
LA534 RA3 RA3 C(CH3)2
LA535 RA14 RA3 C(CH3)2
LA536 RA22 RA3 C(CH3)2
LA537 RA28 RA3 C(CH3)2
LA538 H RA14 C(CH3)2
LA539 RA2 RA14 C(CH3)2
LA540 RA3 RA14 C(CH3)2
LA541 RA14 RA14 C(CH3)2
LA542 RA22 RA14 C(CH3)2
LA543 RA28 RA14 C(CH3)2
LA544 H RA22 C(CH3)2
LA545 RA2 RA22 C(CH3)2
LA546 RA3 RA22 C(CH3)2
LA547 RA14 RA22 C(CH3)2
LA548 RA22 RA22 C(CH3)2
LA549 RA28 RA22 C(CH3)2
LA550 H RA28 C(CH3)2
LA551 RA2 RA28 C(CH3)2
LA552 RA3 RA28 C(CH3)2
LA553 RA14 RA28 C(CH3)2
LA554 RA22 RA28 C(CH3)2
LA555 RA28 RA28 C(CH3)2
LA556 RA2 H C(CH3)2
LA557 RA3 H C(CH3)2
LA558 RA14 H C(CH3)2
LA559 RA22 H C(CH3)2
LA560 RA28 H C(CH3)2
LA561 RA2 RB1 C(CH3)2
LA562 RA3 RB1 C(CH3)2
LA563 RA14 RB1 C(CH3)2
LA564 RA22 RB1 C(CH3)2
LA565 RA28 RB1 C(CH3)2
LA566 RA2 RB2 C(CH3)2
LA567 RA3 RB2 C(CH3)2
LA568 RA14 RB2 C(CH3)2
LA569 RA22 RB2 C(CH3)2
LA570 RA28 RB2 C(CH3)2
LA571 RA2 RB3 C(CH3)2
LA572 RA3 RB3 C(CH3)2
LA573 RA14 RB3 C(CH3)2
LA574 RA22 RB3 C(CH3)2
LA575 RA28 RB3 C(CH3)2
LA576 RA2 RB4 C(CH3)2
LA577 RA3 RB4 C(CH3)2
LA578 RA14 RB4 C(CH3)2
LA579 RA22 RB4 C(CH3)2
LA580 RA28 RB4 C(CH3)2
LA581 RB1 RA2 C(CH3)2
LA582 RB1 RA3 C(CH3)2
LA583 RB1 RA14 C(CH3)2
LA584 RB1 RA22 C(CH3)2
LA585 RB1 RA28 C(CH3)2
LA586 RB2 RA2 C(CH3)2
LA587 RB2 RA3 C(CH3)2
LA588 RB2 RA14 C(CH3)2
LA589 RB2 RA22 C(CH3)2
LA590 RB2 RA28 C(CH3)2
LA591 RB3 RA2 C(CH3)2
LA592 RB3 RA3 C(CH3)2
LA593 RB3 RA14 C(CH3)2
LA594 RB3 RA22 C(CH3)2
LA595 RB3 RA28 C(CH3)2
LA596 RB4 RA2 C(CH3)2
LA597 RB4 RA3 C(CH3)2
LA598 RB4 RA14 C(CH3)2
LA599 RB4 RA22 C(CH3)2
LA600 RB4 RA28 C(CH3)2
LA601 H RA2 NCH3
LA602 RA2 RA2 NCH3
LA603 RA3 RA2 NCH3
LA604 RA14 RA2 NCH3
LA605 RA22 RA2 NCH3
LA606 RA28 RA2 NCH3
LA607 H RA3 NCH3
LA608 RA2 RA3 NCH3
LA609 RA3 RA3 NCH3
LA610 RA14 RA3 NCH3
LA611 RA22 RA3 NCH3
LA612 RA28 RA3 NCH3
LA613 H RA14 NCH3
LA614 RA2 RA14 NCH3
LA615 RA3 RA14 NCH3
LA616 RA14 RA14 NCH3
LA617 RA22 RA14 NCH3
LA618 RA28 RA14 NCH3
LA619 H RA22 NCH3
LA620 RA2 RA22 NCH3
LA621 RA3 RA22 NCH3
LA622 RA14 RA22 NCH3
LA623 RA22 RA22 NCH3
LA624 RA28 RA22 NCH3
LA625 H RA28 NCH3
LA626 RA2 RA28 NCH3
LA627 RA3 RA28 NCH3
LA628 RA14 RA28 NCH3
LA629 RA22 RA28 NCH3
LA630 RA28 RA28 NCH3
LA631 RA2 H NCH3
LA632 RA3 H NCH3
LA633 RA14 H NCH3
LA634 RA22 H NCH3
LA635 RA28 H NCH3
LA636 RA2 RB1 NCH3
LA637 RA3 RB1 NCH3
LA638 RA14 RB1 NCH3
LA639 RA22 RB1 NCH3
LA640 RA28 RB1 NCH3
LA641 RA2 RB2 NCH3
LA642 RA3 RB2 NCH3
LA643 RA14 RB2 NCH3
LA644 RA22 RB2 NCH3
LA645 RA28 RB2 NCH3
LA646 RA2 RB3 NCH3
LA647 RA3 RB3 NCH3
LA648 RA14 RB3 NCH3
LA649 RA22 RB3 NCH3
LA650 RA28 RB3 NCH3
LA651 RA2 RB4 NCH3
LA652 RA3 RB4 NCH3
LA653 RA14 RB4 NCH3
LA654 RA22 RB4 NCH3
LA655 RA28 RB4 NCH3
LA656 RA2 RB1 NCH3
LA657 RA3 RB1 NCH3
LA658 RA14 RB1 NCH3
LA659 RA22 RB1 NCH3
LA660 RA28 RB1 NCH3
LA651 RA2 RB2 NCH3
LA662 RA3 RB2 NCH3
LA663 RA14 RB2 NCH3
LA664 RA22 RB2 NCH3
LA665 RA28 RB2 NCH3
LA666 RA2 RB3 NCH3
LA667 RA3 RB3 NCH3
LA668 RA14 RB3 NCH3
LA669 RA22 RB3 NCH3
LA670 RA28 RB3 NCH3
LA671 RA2 RB4 NCH3
LA672 RA3 RB4 NCH3
LA673 RA14 RB4 NCH3
LA674 RA22 RB4 NCH3
LA675 RA28 RB4 NCH3
LA676 H RA2 N(isobutyl)
LA677 RA2 RA2 N(isobutyl)
LA678 RA3 RA2 N(isobutyl)
LA679 RA14 RA2 N(isobutyl)
LA680 RA22 RA2 N(isobutyl)
LA681 RA28 RA2 N(isobutyl)
LA682 H RA3 N(isobutyl)
LA683 RA2 RA3 N(isobutyl)
LA684 RA3 RA3 N(isobutyl)
LA685 RA14 RA3 N(isobutyl)
LA686 RA22 RA3 N(isobutyl)
LA687 RA28 RA3 N(isobutyl)
LA688 H RA14 N(isobutyl)
LA689 RA2 RA14 N(isobutyl)
LA690 RA3 RA14 N(isobutyl)
LA691 RA14 RA14 N(isobutyl)
LA692 RA22 RA14 N(isobutyl)
LA693 RA28 RA14 N(isobutyl)
LA694 H RA22 N(isobutyl)
LA695 RA2 RA22 N(isobutyl)
LA696 RA3 RA22 N(isobutyl)
LA697 RA14 RA22 N(isobutyl)
LA698 RA22 RA22 N(isobutyl)
LA699 RA28 RA22 N(isobutyl)
LA700 H RA28 N(isobutyl)
LA701 RA2 RA28 N(isobutyl)
LA702 RA3 RA28 N(isobutyl)
LA703 RA14 RA28 N(isobutyl)
LA704 RA22 RA28 N(isobutyl)
LA705 RA28 RA28 N(isobutyl)
LA706 RA2 H N(isobutyl)
LA707 RA3 H N(isobutyl)
LA708 RA14 H N(isobutyl)
LA709 RA22 H N(isobutyl)
LA710 RA28 H N(isobutyl)
LA711 RA2 RB1 N(isobutyl)
LA712 RA3 RB1 N(isobutyl)
LA713 RA14 RB1 N(isobutyl)
LA714 RA22 RB1 N(isobutyl)
LA715 RA28 RB1 N(isobutyl)
LA716 RA2 RB2 N(isobutyl)
LA717 RA3 RB2 N(isobutyl)
LA718 RA14 RB2 N(isobutyl)
LA719 RA22 RB2 N(isobutyl)
LA720 RA28 RB2 N(isobutyl)
LA721 RA2 RB3 N(isobutyl)
LA722 RA3 RB3 N(isobutyl)
LA723 RA14 RB3 N(isobutyl)
LA724 RA22 RB3 N(isobutyl)
LA725 RA28 RB3 N(isobutyl)
LA726 RA2 RB4 N(isobutyl)
LA727 RA3 RB4 N(isobutyl)
LA728 RA14 RB4 N(isobutyl)
LA729 RA22 RB4 N(isobutyl)
LA730 RA28 RB4 N(isobutyl)
LA731 RB1 RA2 N(isobutyl)
LA732 RB1 RA3 N(isobutyl)
LA733 RB1 RA14 N(isobutyl)
LA734 RB1 RA22 N(isobutyl)
LA735 RB1 RA28 N(isobutyl)
LA736 RB2 RA2 N(isobutyl)
LA737 RB2 RA3 N(isobutyl)
LA738 RB2 RA14 N(isobutyl)
LA739 RB2 RA22 N(isobutyl)
LA740 RB2 RA28 N(isobutyl)
LA741 RB3 RA2 N(isobutyl)
LA742 RB3 RA3 N(isobutyl)
LA743 RB3 RA14 N(isobutyl)
LA744 RB3 RA22 N(isobutyl)
LA745 RB3 RA28 N(isobutyl)
LA746 RB4 RA2 N(isobutyl)
LA747 RB4 RA3 N(isobutyl)
LA748 RB4 RA14 N(isobutyl)
LA749 RB4 RA22 N(isobutyl)
LA750 RB4 RA28 N(isobutyl)

wherein RB1 to RB4 have the following structures:

##STR00019##

In some embodiments of the compound, the compound has a structure of Formula III, (LA)nIR(LB)3-n, wherein LB is a bidentate ligand and n is 1, 2, or 3.

In some embodiments of the compound having the structure of Formula III, the ligand LB is selected from the group consisting of:

##STR00020## ##STR00021## ##STR00022##

In some embodiments of the compound having the structure of Formula III, the compound is selected from the group consisting of Compound 1 through Compound 12,750;

wherein each Compound x has the formula Ir(LAk)2(LBj);

wherein x=750j+k−750, k is an integer from 1 to 750, and j is an integer from 1 to 17; and wherein ligands LB1 through LB17 are defined as follows:

##STR00023## ##STR00024## ##STR00025##

In some embodiments of the compound, the compound has a structure of Formula VI, (LA)mPt(LC)2-m, wherein LC is a bidentate ligand, and m is 1, or 2.

In some embodiments of the compound having the structure of Formula VI, m is 1, and LA is connected to LC to form a tetradentate ligand.

According to another aspect of the present disclosure, a first organic light emitting device comprising: an anode; a cathode, and an organic layer disposed between the anode and the cathode is disclosed. The organic layer comprises a compound comprising a ligand LA of Formula I.

##STR00026##
wherein ring A is a 5-membered or 6-membered carbocyclic or heterocyclic ring;

wherein R is fused to ring B and has a structure of Formula II,

##STR00027##
wherein the wave lines indicate bonds to ring B;

wherein R2 represents mono or di substitution, or no substitution;

wherein X1, X2, X3, and X4 are each independently carbon or nitrogen;

wherein at least two adjacent of X1, X2, X3, and X4 are carbon and fuse to R;

wherein X is selected from the group consisting of BR′, NR′, PR′, O, S, Se, C═O, S═O, SO2, CR′R″, SiR′R″, and GeR′R″;

wherein R1, R2, R3, R4, R′, and R″ are each independently selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substituents are optionally joined to form into a ring;

wherein at least one of R3 and R4 comprises a chemical group selected from the group consisting of alkyl, cycloalkyl, partially fluorinated alkyl, partially fluorinated cycloalkyl, and combinations thereof;

wherein LA is coordinated to a metal M;

wherein LA is optionally linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand; and

wherein M is optionally coordinated to other ligands.

The organic light emitting device disclosed herein can be incorporated into one or more of a consumer product, an electronic component module, an organic light-emitting device, and a lighting panel. The organic layer can be an emissive layer and the compound can be an emissive dopant in some embodiments, while the compound can be a non-emissive dopant in other embodiments.

The organic layer can also include a host. In some embodiments, two or more hosts are preferred. In some embodiments, the hosts used may be a) bipolar, b) electron transporting, c) hole transporting or d) wide band gap materials that play little role in charge transport. In some embodiments, the host can include a metal complex. The host can be a triphenylene containing benzo-fused thiophene or benzo-fused furan. Any substituent in the host can be an unfused substituent independently selected from the group consisting of CnH2n+1, OCnH2n+1, OAr1, N(CnH2n+1)2, N(Ar1)(Ar2), CH═CH—CnH2n+1, C≡C—CnH2n+1, Ar1, Ar1-Ar2, and CnH2n—Ar1, or the host has no substitution. In the preceding substituents n can range from 1 to 10; and Ar1 and Ar2 can be independently selected from the group consisting of benzene, biphenyl, naphthalene, triphenylene, carbazole, and heteroaromatic analogs thereof. The host can be an inorganic compound. For example a Zn containing inorganic material e.g. ZnS.

The host can be a compound comprising at least one chemical group selected from the group consisting of triphenylene, carbazole, dibenzothiophene, dibenzofuran, dibenzoselenophene,, azatriphenylene, azacarbazole, aza-dibenzothiophene, aza-dibenzofuran, and aza-dibenzoselenophene. The host can include a metal complex.

The host can be, but is not limited to, a specific compound selected from the group consisting of:

##STR00028## ##STR00029## ##STR00030## ##STR00031##
and combinations thereof. Additional information on possible hosts is provided below.

According to another aspect of the present disclosure, a formulation comprising a compound comprising the ligand LA of Formula I, as defined above, is disclosed. The formulation can include one or more components selected from the group consisting of a solvent, a host, a hole injection material, hole transport material, and an electron transport layer material, disclosed herein.

Combination with Other Materials

The materials described herein as useful for a particular layer in an organic light emitting device may be used in combination with a wide variety of other materials present in the device. For example, emissive dopants disclosed herein may be used in conjunction with a wide variety of hosts, transport layers, blocking layers, injection layers, electrodes and other layers that may be present. The materials described or referred to below are non-limiting examples of materials that may be useful in combination with the compounds disclosed herein, and one of skill in the art can readily consult the literature to identify other materials that may be useful in combination.

Conductivity Dopants:

A charge transport layer can be doped with conductivity dopants to substantially alter its density of charge carriers, which will in turn alter its conductivity. The conductivity is increased by generating charge carriers in the matrix material, and depending on the type of dopant, a change in the Fermi level of the semiconductor may also be achieved. Hole-transporting layer can be doped by p-type conductivity dopants and n-type conductivity dopants are used in the electron-transporting layer. Non-limiting examples of the conductivity dopants that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials:

EP01617493, EP01968131, EP2020694, EP2684932, US20050139810, US20070160905, US20090167167, US2010288362, WO06081780, WO2009003455, WO2009008277, WO2009011327, WO2014009310, US2007252140, US2015060804 and US2012146012.

##STR00032## ##STR00033##
HIL/HTL:

A hole injecting/transporting material to be used in the present invention is not particularly limited, and any compound may be used as long as the compound is typically used as a hole injecting/transporting material. Examples of the material include, but are not limited to: a phthalocyanine or porphyrin derivative; an aromatic amine derivative; an indolocarbazole derivative; a polymer containing fluorohydrocarbon; a polymer with conductivity dopants; a conducting polymer, such as PEDOT/PSS; a self-assembly monomer derived from compounds such as phosphonic acid and silane derivatives; a metal oxide derivative, such as MoOx; a p-type semiconducting organic compound, such as 1,4,5,8,9,12-Hexaazatriphenylenehexacarbonitrile; a metal complex, and a cross-linkable compounds.

Examples of aromatic amine derivatives used in HIL or HTL include, but not limit to the following general structures:

##STR00034##

Each of Ar1 to Ar9 is selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Each Ar may be unsubstituted or may be substituted by a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

In one aspect, Ar1 to Ar9 is independently selected from the group consisting of:

##STR00035##
wherein k is an integer from 1 to 20; X101 to X108 is C (including CH) or N; Z101 is NAr1, O, or S; Ar1 has the same group defined above.

Examples of metal complexes used in HIL or HTL include, but are not limited to the following general formula:

##STR00036##
wherein Met is a metal, which can have an atomic weight greater than 40; (Y101-Y102) is a bidentate ligand. Y101 and Y102 are independently selected from C, N, O, P, and S; L101 is an ancillary ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.

In one aspect, (Y101-Y102) is a 2-phenylpyridine derivative. In another aspect, (Y101-Y102) is a carbene ligand. In another aspect, Met is selected from Ir, Pt, Os, and Zn. In a further aspect, the metal complex has a smallest oxidation potential in solution vs. Fc+/Fc couple less than about 0.6 V.

Non-limiting examples of the HIL and HTL materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials:

CN102702075, DE102012005215, EP01624500, EP01698613, EP01806334, EP01930964, EP01972613, EP01997799, EP02011790, EP02055700, EP02055701, EP1725079, EP2085382, EP2660300, EP650955, JP07073529, JP2005112765, JP2007091719, JP2008021687, JP2014-009196, KR20110088898, KR20130077473, TW201139402, U.S. Pat. No. 6,517,957. US20020158242, US20030162053, US20050123751, US20060182993, US20060240279, US20070145888, US20070181874, US20070278938, US20080014464, US20080091025, US20080106190, US20080124572, US20080145707, US20080220265, US20080233434, US20080303417, US2008107919, US20090115320, US20090167161, US2009066235, US2011007385, US20110163302, US2011240968, US2011278551, US2012205642, US2013241401, US20140117329, US2014183517, U.S. Pat. No. 5,061,569, U.S. Pat. No. 5,639,914, WO05075451, WO07125714, WO08023550, WO08023759, WO2009145016, WO2010061824, WO2011075644, WO2012177006, WO02013018530, WO2013039073, WO2013087142, WO2013118812, WO2013120577, WO2013157367, WO2013175747, WO2014002873, WO2014015935, WO2014015937, WO2014030872, WO2014030921, WO2014034791, WO2014104514, WO2014157018.

##STR00037## ##STR00038## ##STR00039## ##STR00040## ##STR00041## ##STR00042## ##STR00043## ##STR00044## ##STR00045## ##STR00046## ##STR00047## ##STR00048## ##STR00049## ##STR00050##
EBL:

An electron blocking layer (EBL) may be used to reduce the number of electrons and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies, and or longer lifetime, as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than the emitter closest to the EBL interface. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and or higher triplet energy than one or more of the hosts closest to the EBL interface. In one aspect, the compound used in EBL contains the same molecule or the same functional groups used as one of the hosts described below.

Host:

The light emitting layer of the organic EL device of the present invention preferably contains at least a metal complex as light emitting material, and may contain a host material using the metal complex as a dopant material. Examples of the host material are not particularly limited, and any metal complexes or organic compounds may be used as long as the triplet energy of the host is larger than that of the dopant. While the Table below categorizes host materials as preferred for devices that emit various colors, any host material may be used with any dopant so long as the triplet criteria is satisfied.

Examples of metal complexes used as host are preferred to have the following general formula:

##STR00051##
wherein Met is a metal; (Y103-Y104) is a bidentate ligand, Y103 and Y104 are independently selected from C, N, O, P, and S; L101 is an another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.

In one aspect, the metal complexes are:

##STR00052##
wherein (O—N) is a bidentate ligand, having metal coordinated to atoms O and N.

In another aspect, Met is selected from Ir and Pt. In a further aspect, (Y103-Y104) is a carbene ligand.

Examples of organic compounds used as host are selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Each option within each group may be unsubstituted or may be substituted by a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

In one aspect, the host compound contains at least one of the following groups in the molecule:

##STR00053## ##STR00054##
wherein each of R101 to R107 is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, and when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. k is an integer from 0 to 20 or 1 to 20; k″′ is an integer from 0 to 20. X101 to X108 is selected from C (including CH) or N.
Z101 and Z102 is selected from NR101, O, or S.

Non-limiting examples of the Host materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials:

EP2034538, EP2034538A, EP2757608, JP2007254297. KR20100079458, KR20120088644, KR20120129733, KR20130115564, TW201329200, US20030175553, US20050238919, US20060280965, US20090017330, US20090030202, US20090167162, US20090302743, US20090309488, US20100012931, US20100084966, US20100187984, US2010187984, US2012075273, US2012126221, US2013009543, US2013105787, US2013175519, US2014001446, US20140183503, US20140225088, US2014034914, U.S. Pat. No. 7,154,114, WO2001039234, WO2004093207, WO2005014551, WO2005089025, WO2006072002, WO2006114966, WO2007063754, WO2008056746, WO2009003898, WO2009021126, WO2009063833, WO2009066778, WO2009066779, WO2009086028, WO2010056066, WO2010107244, WO2011081423, WO2011081431, WO2011086863, WO2012128298, WO2012133644, WO2012133649, WO2013024872, WO2013035275, WO2013081315, WO2013191404, WO2014142472.

##STR00055## ##STR00056## ##STR00057## ##STR00058## ##STR00059## ##STR00060## ##STR00061## ##STR00062## ##STR00063## ##STR00064## ##STR00065## ##STR00066## ##STR00067## ##STR00068##
Emitter:

An emitter example is not particularly limited, and any compound may be used as long as the compound is typically used as an emitter material. Examples of suitable emitter materials include, but are not limited to, compounds which can produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence, i.e., TADF (also referred to as E-type delayed fluorescence), triplet-triplet annihilation, or combinations of these processes.

Non-limiting examples of the emitter materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN103694277, CN1696137, EB01238981, EP01239526, EP01961743, EP1239526, EP1244155, EP1642951, EP1647554, EP1841834, EP1841834B, EP2062907, EP2730583, JP2012074444, JP2013110263, JP4478555. KR1020090133652, KR20120032054, KR20130043460, TW201332980, U.S. Pat. No. 6,699,599, U.S. Pat. No. 6,916,554, US20010019782, US20020034656. US20030068526, US20030072964, US20030138657, US20050123788, US20050244673, US2005123791, US2005260449, US20060008670, US20060065890, US20060127696, US20060134459, US20060134462, US20060202194, US20060251923, US20070034863, US20070087321, US20070103060, US20070111026, US20070190359, US20070231600, US2007034863, US2007104979, US2007104980, US2007138437, US2007224450, US2007278936, US20080020237, US20080233410, US20080261076, US20080297033, US200805851, US2008161567, US2008210930, US20090039776, US20090108737, US20090115322, US20090179555, US2009085476, US2009104472, US20100090591, US20100148663, US20100244004, US20100295032, US2010102716, US2010105902, US2010244004, US2010270916, US20110057559, US20110108822, US20110204333, US2011215710, US2011227049, US2011285275, US2012292601, US20130146848, US2013033172, US2013165653, US2013181190, US2013334521, US20140246656, US2014103305. U.S. Pat. No. 6,303,238, U.S. Pat. No. 6,413,656. U.S. Pat. No. 6,653,654. U.S. Pat. No. 6,670,645, U.S. Pat. No. 6,687,266, U.S. Pat. No. 6,835,469, U.S. Pat. No. 6,921,915, U.S. Pat. No. 7,279,704, U.S. Pat. No. 7,332,232, U.S. Pat. No. 7,378,162, U.S. Pat. No. 7,534,505, U.S. Pat. No. 7,675,228. U.S. Pat. No. 7,728,137, U.S. Pat. No. 7,740,957, U.S. Pat. No. 7,759,489, U.S. Pat. No. 7,951,947, U.S. Pat. No. 8,067,099, U.S. Pat. No. 8,592,586. U.S. Pat. No. 8,871,361, WO06081973, WO06121811, WO07018067, WO07108362, WO07115970, WO07115981, WO08035571, WO2002015645, WO2003040257, WO2005019373, WO2006056418, WO2008054584, WO2008078800, WO2008096609, WO2008101842, WO2009000673, WO2009050281, WO2009100991, WO2010028151, WO2010054731, WO2010086089, WO2010118029, WO2011044988, WO2011051404, WO2011107491, WO2012020327, WO2012163471, WO2013094620, WO2013107487, WO2013174471, WO2014007565, WO2014008982, WO2014023377, WO2014024131, WO2014031977, WO2014038456, WO2014112450.

##STR00069## ##STR00070## ##STR00071## ##STR00072## ##STR00073## ##STR00074## ##STR00075## ##STR00076## ##STR00077## ##STR00078## ##STR00079## ##STR00080## ##STR00081## ##STR00082## ##STR00083## ##STR00084## ##STR00085## ##STR00086## ##STR00087## ##STR00088## ##STR00089## ##STR00090## ##STR00091## ##STR00092## ##STR00093## ##STR00094##
HBL:

A hole blocking layer (HBL) may be used to reduce the number of holes and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies and/or longer lifetime as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and or higher triplet energy than the emitter closest to the HBL interface. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and or higher triplet energy than one or more of the hosts closest to the HBL interface.

In one aspect, compound used in HBL contains the same molecule or the same functional groups used as host described above.

In another aspect, compound used in HBL contains at least one of the following groups in the molecule:

##STR00095##
wherein k is an integer from 1 to 20; L101 is an another ligand, k′ is an integer from 1 to 3.
ETL:

Electron transport layer (ETL) may include a material capable of transporting electrons. Electron transport layer may be intrinsic (undoped), or doped. Doping may be used to enhance conductivity. Examples of the ETL material are not particularly limited, and any metal complexes or organic compounds may be used as long as they are typically used to transport electrons.

In one aspect, compound used in ETL contains at least one of the following groups in the molecule:

##STR00096##
wherein R101 is selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. Ar1 to Ar3 has the similar definition as Ar's mentioned above. k is an integer from 1 to 20. X101 to X108 is selected from C (including CH) or N.

In another aspect, the metal complexes used in ETL contains, but not limit to the following general formula:

##STR00097##
wherein (O—N) or (N—N) is a bidentate ligand, having metal coordinated to atoms O, N or N, N; L101 is another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal.

Non-limiting examples of the ETL materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN103508940, EP01602648, EP01734038, EP01956007, JP2004-022334, JP2005149918, JP2005-268199, KR0117693, KR20130108183, US20040036077, US20070104977, US2007018155, US20090101870, US20090115316, US20090140637, US20090179554, US2009218940, US2010108990, US2011156017, US2011210320, US2012193612, US2012214993, US2014014925, US2014014927, US20140284580, U.S. Pat. No. 6,656,612, U.S. Pat. No. 8,415,031, WO2003060956, WO2007111263, WO2009148269, WO2010067894, WO2010072300, WO2011074770, WO2011105373, WO2013079217, WO2013145667, WO2013180376, WO2014104499, WO2014104535.

##STR00098## ##STR00099## ##STR00100## ##STR00101## ##STR00102## ##STR00103## ##STR00104## ##STR00105## ##STR00106## ##STR00107##
Charge Generation Layer (CGL)

In tandem or stacked OLEDs, the CGL plays an essential role in the performance, which is composed of an n-doped layer and a p-doped layer for injection of electrons and holes, respectively. Electrons and holes are supplied from the CGL and electrodes. The consumed electrons and holes in the CGL are refilled by the electrons and holes injected from the cathode and anode, respectively; then, the bipolar currents reach a steady state gradually. Typical CGL materials include n and p conductivity dopants used in the transport layers.

In any above-mentioned compounds used in each layer of the OLED device, the hydrogen atoms can be partially or fully deuterated. Thus, any specifically listed substituent, such as, without limitation, methyl, phenyl, pyridyl, etc. may be undeuterated, partially deuterated, and fully deuterated versions thereof. Similarly, classes of substituents such as, without limitation, alkyl, aryl, cycloalkyl, heteroaryl, etc. also may be undeuterated, partially deuterated, and fully deuterated versions thereof.

Materials Synthesis

All reactions were carried out under nitrogen protections unless specified otherwise. All solvents for reactions are anhydrous and used as received from commercial sources.

Synthesis of Compound 3676

##STR00108##

4-chloro-7-isopropylthieno[3,2-d]pyrimidine (4.50 g, 21.2 mmol). Pd(PPh3)4 (0.73 g, 0.64 mmol), potassium carbonate (7.31 g, 52.9 mmol), tetrahydrofuran (THF) (200 ml), and water (50.0 ml) were combined in a flask. The mixture was degassed by bubbling nitrogen gas for 15 minutes and the reaction was then heated to reflux overnight. The reaction was extracted with ethyl acetate and washed with brine, dried with sodium sulfate, filtered and concentrated down. The brown oil was purified with silica gel using DCM to 90/10 DCM % ethyl acetate solvent system. The orange oil was further purified with silica gel using 75/25 hept/ethyl acetate solvent system to get 5.50 g of a white solid for a 90% yield.

Synthesis of the Ir(III) Dimer

##STR00109##

4-(3,5-dimethylphenyl)-7-isopropylthieno[3,2-d]pyrimidine (3.07 g, 10.9 mmol) was inserted in a flask and was solubilized in 2-ethoxyethanol (40 mL) and Water (13 mL). The mixture was degassed by bubbling nitrogen gas for 15 minutes then IrCl3H8O4 (1.15 g, 3.10 mmol) was inserted. The reaction was heated at 105° C. for 24 hours under nitrogen. The reaction was cooled down to room temperature, diluted with 10 mL of MeOH, filtered and washed with MeOH to obtain 1.6 g of a solid for a 65% yield.

Synthesis of Compound 3676

##STR00110##

The Ir(III) dimer (1.00 g, 0.63 mmol), 3,7-diethylnonane-4,6-dione (1.34 g, 6.33 mmol) and 2-ethoxyethanol (15 ml) were combined in a flask. Nitrogen was bubbled into the suspension for 15 minutes and potassium carbonate (0.87 g, 6.33 mmol) was added. The rxn was stirred at room temperature overnight. The mixture was filtered through celite using dichloromethane (DCM) and the filtrate was concentrated down. The solid was triturated in 100 mL of MeOH and the solid was filtered off. The solid was purified with silica gel (Pre-treated with Triethylamine) using 95/5 to 90/10 hept/DCM to afford 0.45 g of the title compound (37% yield).

Synthesis of Compound 6796

##STR00111##

4,6,7-trichlorothieno[3,2-d]pyrimidine (12.0 g, 50.1 mmol), (3,5-dimethylphenyl)boronic acid (8.27 g, 55.1 mmol), potassium carbonate (17.3 g, 125 mmol), THF (300 mL), and Water (75 mL) were combined in a flask. The solution was purged with nitrogen for 15 min then palladium tetrakis (1.74 g, 1.503 mmol) was added. The reaction was heated to reflux under nitrogen overnight. The reaction mixture was extracted with ethyl acetate (3 times), then washed with Brine and Water. The yellow solid was purified with silica gel using 90/10 hept/EtOac as the solvent system to afford a white solid. The sample was further purified with silica gel using DCM to 95/5 DCM/EtOac as the solvent system to get 8.4 g of a white solid for a 54% yield.

##STR00112##

6,7-dichloro-4-(3,5-dimethylphenyl)thieno[3,2-d]pyrimidine (5.00 g, 16.2 mmol), palladium(II) acetate (0.73 g, 3.23 mmol), and 2′-(dicyclohexylphosphanyl)-N2,N2,N6,N6-tetramethyl-[1,1′-biphenyl]-2,6-diamine (CPhos) (2.82 g, 6.47 mmol) were combined in an oven dried flask. The system was purged with nitrogen then THF (50 mL) was added via syringe. The reaction was stirred for 15 min, then (3,3,3-trifluoropropyl)zinc(II) iodide (300 mL, 64.7 mmol) was added quickly via syringe. The reaction was stirred at room temperature overnight and then it was quenched with sodium bicarbonate solution The mixture was extracted 3 times with ethyl acetate and the suspension was filtered through celite to remove the insoluble solids. The organic phase was washed twice with brine, dried with sodium sulfate, filtered and concentrated down to a brown oil. The crude product was purified with silica gel using 90/10 heptanes/ethyl acetate to get a light brown oil. The sample was further purified with C18 columns using 70/30 to 90/10 acetonitrile/water as the solvent system to afford 2.56 g of a white solid for a 37% yield.

Synthesis of the Ir(III) Dimer

##STR00113##

4-(3,5-dimethylphenyl)-6,7-bis(3,3,3-trifluoropropyl)thieno[3,2-d]pyrimidine (2.86 g, 6.61 mmol), 2-ethoxy ethanol (24 mL) and water (8 mL) were combined in a flask. Nitrogen was bubbled into the reaction for 15 minutes, then IrCl3H8O4 (0.70 g, 1.89 mmol) was added. The reaction was heated at 105° C. overnight under nitrogen. The reaction was cooled and diluted with 10 mL of MeOH, filtered and washed with MeOH to afford 2.28 g (Quantitative Yield) of an orange-red solid.

Synthesis of Compound 6796

##STR00114##

The Ir(III) dimer (2.10 g, 1.59 mmol), 3,7-diethyl-5-methylnonane-4,6-dione (4.0 ml, 15.9 mmol) and 2-ethoxyethanol (30 ml) were combined in a flask. Nitrogen was bubbled into the suspension for 15 minutes then potassium carbonate (2.20 g, 15.9 mmol) was added. The reaction was stirred at room temperature overnight. Upon completion of the reaction, the reaction was diluted in DCM and was filtered through celite. The red oil was triturated in 75 mL of hot MeOH, cooled to room temperature and then filtered off. The solid was purified with silica gel (Pre-treated with Triethylamine) using 95/5 to 85/15 of heptanes/DCM solvent system to afford 1.41 g of the title compound (35% yield).

Synthesis of Compound 6841

##STR00115##

4-(3,5-dimethylphenyl)-7-isopropylthieno[3,2-d]pyrimidine (5.00 g, 17.7 mmol) was added to an oven-dried flask. The system was evacuated and purged with nitrogen three times. THF (200 mL) was added and the solution was cooled to −70° C., then 2.5 M butyllithium (8.5 mL, 21.3 mmol) was added dropwise. The reaction was stirred for three hours at this temperature, then dibromine (1.0 mL, 19.5 mmol) was added dropwise. The reaction was stirred for 30 minutes at −70° C. then it was allowed warm up to room temperature and stirred overnight. The mixture was quenched with water and extracted with ethyl acetate and washed twice with brine, dried with sodium sulfate, filtered and concentrated down to an orange-yellow solid. The crude product was purified with silica gel using 95/5 to 90/10 heptane/EtOac solvent system to obtain an off-white solid. The purification with silica gel was repeated using 97.5/2.5 to 95/5 heptane/EtOac solvent system to get 5.10 g of a white solid for an 80% yield.

##STR00116##

6-bromo-4-(3,5-dimethylphenyl)-7-isopropylthieno[3,2-d]pyrimidine (4.50 g, 12.5 mmol), palladium(II) acetate (0.11 g, 0.50 mmol), and 2′-(dicyclohexylphosphanyl)-N2,N2,N6,N6-tetramethyl-[1,1′-biphenyl]-2,6-diamine (Cphos) (0.44 g, 1.00 mmol) were combined in an oven dried flask. The solids were solubilized in THF (50 mL) and the reaction was stirred for 15 min, then (3,3,3-trifluoro-2,2-dimethylpropyl)zinc(II) bromide (110 ml, 24.9 mmol) was added via syringe and the mixture was stirred overnight. The reaction was quenched with sodium bicarbonate solution, extracted with ethyl acetate (3 times). The combined organics were washed twice with brine, dried with sodium sulfate, filtered and concentrated down. The crude product was purified with silica gel using 85/15 heptane/ethyl acetate to get 5.0 g of a brown oil. The product was purified again with silica gel using 97.5/2.5 to 95/5 heptane/ethyl acetate to get 4.1 g of a clear oil which changed to a white solid for an 80% yield.

Synthesis of the Ir(III) Dimer

##STR00117##

4-(3,5-dimethylphenyl)-7-isopropyl-6-(3,3,3-trifluoro-2,2-dimethylpropyl)thieno[3,2-d]pyrimidine (3.84 g, 9.44 mmol), 2-ethoxyethanol (34 mL), and water (11 mL were combined in a flask. The mixture was degassed by bubbling nitrogen gas for 15 minutes, then IrCl3H8O4 (1.00 g, 2.70 mmol) was added. The reaction was heated at 105° C. for 24 hours. The reaction was cooled down to room temperature, diluted with 30 ml MeOH, then the product was filtered and washed with MeOH to afford 2.50 g (Quantitative yield).

Synthesis of Compound 6841

##STR00118##

The Ir(II) dimer (2.00 g, 1.58 mmol), 3,7-diethyl-5-methylnonane-4,6-dione (3.58 g, 15.8 mmol) and 2-ethoxyethanol (30 ml) were combined in a flask. Nitrogen was bubbled into the suspension for 15 min. and then potassium carbonate (2.18 g, 15.8 mmol) was added. The reaction was stirred at room temperature overnight. The mixture was filtered through celite using DCM and the filtrate was concentrated down. The solid was triturated in 100 mL of MeOH and the solid was filtered off. The solid was purified with silica gel (Pre-treated with Triethylamine) using 90/10 hept/DCM to afford 1.20 g of the title compound (31% yield).

Synthesis of Compound 6836

##STR00119##

The Ir(III) dimer (1.80 g, 1.14 mmol), 3,7-diethyl-5-methylnonane-4,6-dione (2.9 mL, 11.4 mmol) and 2-ethoxyethanol (25 ml) were combined in a flask. Nitrogen was bubbled into the suspension for 15 minutes and then potassium carbonate (1.57 g, 11.4 mmol) was added. The reaction was stirred at room temperature overnight. The mixture was filtered through celite using DCM and the filtrate was concentrated down. The solid was triturated in 100 mL of MeOH and was filtered off. The crude product was purified with silica gel (Pre-treated with Triethylamine) using 95/5 to 90/10 heptanes/DCM to afford 1.20 g of the title compound (54% yield).

Synthesis of Comparative Compound 1

Synthesis of the Ir(III) Dimer

##STR00120##

7-(3,5-dimethylphenyl)thieno[2,3-c]pyridine (2.063 g, 8.62 mmol) was solubilized in Ethoxyethanol (26 mL) and Water (9 mL). The mixture was degassed by bubbling nitrogen gas for 15 minutes and then iridium(II) chloride trihydrate (0.80 g, 2.269 mmol) was inserted and the reaction was heated at 105° C. for 24 hours. The reaction was cooled down to room temperature, diluted with 10 mL of MeOH, filtered and washed with MeOH to afford 1.20 g (75% yield) of the product.

Synthesis of Comparative Compound 1

##STR00121##

The Ir(III) Dimer (1.15 g, 0.82 mmol), 3,7-diethylnonane-4,6-dione (1.30 g, 6.12 mmol) and 2-ethoxyethanol (14 mL) were combined and the mixture was purged with nitrogen for 15 minutes Potassium carbonate (0.85 g, 6.12 mmol) was added and the reaction was stirred at room temperature overnight. The mixture was solubilized in DCM and filtered through a pad of Celite. The solvent were rotovaped down and the mixture was triturated from methanol and filtered. The crude material was further purified via column chromatography (pre-treated with triethylamine) using a Heptanes % DCM (95/5) solvent system. The product was then recrystallized from a DCM/MeOH mixture to afford 1.30 g (90%/o yield) of an orange powder.

Device Examples

All example devices were fabricated by high vacuum (<10−7 Torr) thermal evaporation. The anode electrode was 1150 Å of indium tin oxide (ITO). The cathode consisted of 10 Å of Liq (8-hydroxyquinoline lithium) followed by 1,000 Å of Al. All devices were encapsulated with a glass lid sealed with an epoxy resin in a nitrogen glove box (<1 ppm of H2O and O2) immediately after fabrication, and a moisture getter was incorporated inside the package. The organic stack of the device examples consisted of sequentially, from the ITO surface, 100 Å of LG101 (purchased from LG chem) as the hole injection layer (HIL); 400 Å of HTM as a hole transporting layer (HTL); 300 Å of an emissive layer (EML) containing Compound H as a host (a stability dopant (SD) (18%), and Comparative Compound 1 or Compounds 3676, 6836, and 6841 as the emitter (3%); 100 Å of Compound H as a blocking layer; and 350 Å of Liq (8-hydroxyquinoline lithium) doped with 40% of ETM as the ETL. The emitter was selected to provide the desired color, efficiency and lifetime. The stability dopant (SD) was added to the electron-transporting host to help transport positive charge in the emissive layer. The Comparative Example device was fabricated similarly to the device examples except that Comparative Compound 1 was used as the emitter in the EML. Table 3 below shows the device layer thickness and materials. The chemical structures of the materials used in the devices are shown in Table 5 below.

The device performance data are summarized in Table 4 below. Inventive compounds have much longer lifetime vs. comparative compound 1. Also Compounds 3676, 6836, and 6841 have superior performance to Comparative Compound 1 in color saturation as a red shift of 28 to 38 nm was observed. Moreover, the inventive compounds afforded either similar or higher EQE than Comparative Compound 1.

TABLE 3
Device layer materials and thicknesses
Layer Material Thickness [Å]
Anode ITO 1150
HIL LG101 (LG Chem) 100
HTL HTM 400
EML Compound H: SD 18%: 300
Emitter 3%
BL Compound H 100
ETL Liq: ETM 40% 350
EIL Liq 10
Cathode Al 1000

TABLE 4
Device performance data
At 10 mA/cm2 At 80 mA/cm2
Device 1931 CIE λ max FWHM Voltage EQE LT95%
Example Emitter x y [nm] [nm] [V] [%] [h]
Example 1 Compound 0.649 0.349 618 54 1.00 1.04 11.5
6841
Example 2 Compound 0.650 0.348 617 59 1.00 0.92 9.82
6836
Example 3 Compound 0.629 0.369 608 55 1.03 1.00 7.91
3676
CE1 Comparative 0.547 0.451 580 48 1.00 1.00 1
Compound 1

TABLE 5
Materials used in the OLED devices
##STR00122## COMPOUND H
##STR00123##
##STR00124## Comparative Compound 1
##STR00125##
##STR00126##
##STR00127##
##STR00128## Compound 6841
##STR00129## Compound 6836
##STR00130## Compound 3676

It is understood that the various embodiments described herein are by way of example only, and are not intended to limit the scope of the invention. For example, many of the materials and structures described herein may be substituted with other materials and structures without deviating from the spirit of the invention. The present invention as claimed may therefore include variations from the particular examples and preferred embodiments described herein, as will be apparent to one of skill in the art. It is understood that various theories as to why the invention works are not intended to be limiting.

Boudreault, Pierre-Luc T., Xia, Chuanjun, Wendt, Harvey

Patent Priority Assignee Title
Patent Priority Assignee Title
10164199, Dec 03 2014 Industrial Technology Research Institute Organic metal compound and organic light-emitting device employing the same
10340466, Nov 26 2015 Industrial Technology Research Institute Organic metal compound, organic light-emitting devices employing the same
10547013, May 15 2015 UNIVERSAL DISPLAY CORPORATION Organic electroluminescent materials and devices
4769292, Mar 02 1987 Eastman Kodak Company Electroluminescent device with modified thin film luminescent zone
5061569, Jul 26 1990 Global Oled Technology LLC Electroluminescent device with organic electroluminescent medium
5247190, Apr 20 1989 Cambridge Display Technology Limited Electroluminescent devices
5703436, Dec 13 1994 TRUSTEES OF PRINCETON UNIVERSITY, THE Transparent contacts for organic devices
5707745, Dec 13 1994 The Trustees of Princeton University Multicolor organic light emitting devices
5834893, Dec 23 1996 TRUSTEES OF PRINCETON UNIVERSITY, THE High efficiency organic light emitting devices with light directing structures
5844363, Jan 23 1997 TRUSTEES OF PRINCETON UNIVERSITY, THE Vacuum deposited, non-polymeric flexible organic light emitting devices
6013982, Dec 23 1996 TRUSTEES OF PRINCETON UNIVERSITY, THE; UNIVERSITY OF SOUTHERN CALIFORNIA, THE Multicolor display devices
6087196, Jan 30 1998 PRINCETON UNIVERSITY, THE TRUSTEES OF Fabrication of organic semiconductor devices using ink jet printing
6091195, Feb 03 1997 TRUSTEES OF PRINCETON UNIVERSITY, THE Displays having mesa pixel configuration
6097147, Sep 14 1998 TRUSTEES OF PRINCETON UNIVERSITY, THE Structure for high efficiency electroluminescent device
6294398, Nov 23 1999 TRUSTEES OF PRINCETON UNIVERSITY, THE Method for patterning devices
6303238, Dec 01 1997 SOUTHERN CALIFORNIA, UNIVERSITY OF, THE OLEDs doped with phosphorescent compounds
6337102, Nov 17 1997 TRUSTEES OF PRINCETON UNIVERSITY, THE Low pressure vapor phase deposition of organic thin films
6468819, Nov 23 1999 TRUSTEES OF PRINCETON UNIVERSITY, THE Method for patterning organic thin film devices using a die
6528187, Sep 08 1998 UDC Ireland Limited Material for luminescence element and luminescence element using the same
6687266, Nov 08 2002 UNIVERSAL DISPLAY CORPORATION Organic light emitting materials and devices
6835469, Oct 17 2001 TRUSTEES OF PRINCETON UNIVERSITY, THE Phosphorescent compounds and devices comprising the same
6921915, Mar 08 2001 SAMSUNG ELECTRONICS CO , LTD Metal coordination compound, luminescence device and display apparatus
7087321, Apr 22 2003 University Display Corporation Organic light emitting devices having reduced pixel shrinkage
7090928, Apr 01 2003 The University of Southern California Binuclear compounds
7154114, May 18 2004 University Display Corporation Cyclometallated iridium carbene complexes for use as hosts
7250226, Aug 31 2001 Nippon Hoso Kyokai; Showa Denko K K Phosphorescent compound, a phosphorescent composition and an organic light-emitting device
7279704, May 18 2004 UNIVERSITY OF SOUTHERN CALIFORNIA, THE; UNIVERSAL DISPLAY CORPORATION Complexes with tridentate ligands
7332232, Feb 03 2004 UNIVERSAL DISPLAY CORPORATION OLEDs utilizing multidentate ligand systems
7338722, Mar 24 2003 UNIVERSITY OF SOUTHERN CALIFORNIA, THE Phenyl and fluorenyl substituted phenyl-pyrazole complexes of Ir
7393599, May 18 2004 UNIVERSITY OF SOUTHERN CALIFORNIA, THE Luminescent compounds with carbene ligands
7396598, Jun 20 2001 SAMSUNG ELECTRONICS CO , LTD Light emitting material and organic light-emitting device
7431968, Sep 04 2001 TRUSTEES OF PRINCETON UNIVERSITY, THE Process and apparatus for organic vapor jet deposition
7445855, May 18 2004 UNIVERSAL DISPLAY CORPORATION Cationic metal-carbene complexes
7534505, May 18 2004 UNIVERSAL DISPLAY CORPORATION Organometallic compounds for use in electroluminescent devices
8564192, May 11 2011 UNIVERSAL DISPLAY CORPORATION Process for fabricating OLED lighting panels
20020034656,
20020134984,
20020158242,
20030138657,
20030152802,
20030162053,
20030175553,
20030230980,
20040036077,
20040137267,
20040137268,
20040174116,
20050025993,
20050112407,
20050238919,
20050244673,
20050260441,
20050260449,
20060008670,
20060134462,
20060202194,
20060240279,
20060251923,
20060263635,
20060280965,
20070122655,
20070190359,
20070278938,
20080015355,
20080018221,
20080106190,
20080124572,
20080220265,
20080297033,
20090008605,
20090009065,
20090017330,
20090030202,
20090039776,
20090045730,
20090045731,
20090101870,
20090108737,
20090115316,
20090165846,
20090167162,
20090179554,
20110285275,
20120061654,
20130033171,
20130033172,
20130324721,
20140158998,
20150097169,
20150188059,
20160164007,
CN104447880,
DE102011111328,
EP650955,
EP1725079,
EP2034538,
JP200511610,
JP2007123392,
JP2007254297,
JP2008074939,
JP2017141218,
TW678410,
WO139234,
WO2015654,
WO202714,
WO3040257,
WO3060956,
WO4107822,
WO2004093207,
WO2005014551,
WO2005019373,
WO2005030900,
WO2005089025,
WO2005123873,
WO2006009024,
WO2006056418,
WO2006072002,
WO2006082742,
WO2006098120,
WO2006100298,
WO2006103874,
WO2006114966,
WO2006132173,
WO2007002683,
WO2007004380,
WO2007063754,
WO2007063796,
WO2008056746,
WO2008101842,
WO2008132085,
WO2009000673,
WO2009003898,
WO2009008311,
WO2009018009,
WO2009021126,
WO2009050290,
WO2009062578,
WO2009063833,
WO2009066778,
WO2009066779,
WO2009086028,
WO2009100991,
WO2015104045,
WO2015117718,
////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Mar 16 2016WENDT, HARVEYUNIVERSAL DISPLAY CORPORATIONNUNC PRO TUNC ASSIGNMENT SEE DOCUMENT FOR DETAILS 0558590684 pdf
Mar 17 2016XIA, CHUANJUNUNIVERSAL DISPLAY CORPORATIONNUNC PRO TUNC ASSIGNMENT SEE DOCUMENT FOR DETAILS 0558590684 pdf
Mar 21 2016BOUDREAULT, PIERRE-LUC T UNIVERSAL DISPLAY CORPORATIONNUNC PRO TUNC ASSIGNMENT SEE DOCUMENT FOR DETAILS 0558590684 pdf
Sep 26 2019UNIVERSAL DISPLAY CORPORATION(assignment on the face of the patent)
Date Maintenance Fee Events
Sep 26 2019BIG: Entity status set to Undiscounted (note the period is included in the code).


Date Maintenance Schedule
Nov 02 20244 years fee payment window open
May 02 20256 months grace period start (w surcharge)
Nov 02 2025patent expiry (for year 4)
Nov 02 20272 years to revive unintentionally abandoned end. (for year 4)
Nov 02 20288 years fee payment window open
May 02 20296 months grace period start (w surcharge)
Nov 02 2029patent expiry (for year 8)
Nov 02 20312 years to revive unintentionally abandoned end. (for year 8)
Nov 02 203212 years fee payment window open
May 02 20336 months grace period start (w surcharge)
Nov 02 2033patent expiry (for year 12)
Nov 02 20352 years to revive unintentionally abandoned end. (for year 12)